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Abstract 
The presence of natural killer cells at lower evolutionary levels was 
investigated in the amphibian Xenopus laevis. Chromium release microcytotoxicity 
assays revealed that fresh splenocytes from early-thymectomised Xenopus displayed 
significant spontaneous cytotoxicity against allogeneic B3B7 thymic tumor cell 
targets, unlike those from control Xenopus, suggesting that 'NK-like ' activity is 
greater in thymectomised (T cell-deficient) animals. Addition of Concanavalin A-
derived active supernatants to splenocytes from a thymectomised animal caused a 
significant increase in cytolytic activity, but had no effect on cells from a control 
animal. This finding o f enhanced cytotoxicity was indicative o f lymphokine-activated 
killing in Xenopt/s, and supported the concept that tumour cell lysis was mediated by 
N K - like cells. 
Attempts were made to enrich the splenocytes for natural killer cells through 
the selective depletion o f other lymphocyte subsets, using the techniques of'panning' 
and 'magnetic bead' separation following monoclonal antibody labelling o f cells. On 
comparison o f the two techniques, it was found that both were able to deplete a 
splenocyte culture o f B cells to the same extent, but that magnetic sorting produced 
far superior results for depletion of T cells. Optimum conditions for magnetic sorting 
were determined, and used to generate 'purified' populations which were tested for 
their cytolytic activity. Such preliminary investigations suggested that natural killer-
like activity in Xenopus is likely to be mediated by a 'non-T / non-B' lymphoid 
subset. 
Finally, preliminary work was undertaken into the development o f 'phage 
display' technology for the generation o f single chain Fy antibody fragments 
(ultimately against N K cell surface antigens). PCR amplification of the V H and 
Kappa chains was attempted on RNA extracted (using various methods) from 
Carboxypeptidase Y-injected-, BjBT-injected-, and unimmunised mice. Following 
R N A extraction under optimum conditions. Kappa chains were successfully amplified 
from experimental spleens, but the heavy chains still require more development. 
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Chapter 1 
General Introduction 
1.1 Natural Killer Cells - Characterisation and Functions 
Natural Killer cells represent a unique population of lymphocytes that are 
capable o f spontaneous cytotoxicity, and are thus believed to form a first line of 
defence within the immune system. They were initially recognised for their 
tumouricidal activity but are now believed to be important in destroying virally-
infected cells too. Since they require no prior sensitisation to lyse their targets, and 
are not genetically restricted, they provide an excellent means of first line defence. 
Further, their effect is usually very rapid - N K cell subsets requiring assistance fi'om 
accessory cells usually reach maximum cytolytic activity within fourteen hours, while 
those independent o f accessory cell assistance can achieve maximum killing in only 
four hours (Howell and Fitzgerald-Bocarsly, 1991). However, N K cells do not 
generate immunological memory like T- and B- cells, nor do they possess a clonally 
distributed receptor (Brooks et al, 1983), which suggests that evolutionarily they 
existed before T and B cells, providing a multi-specific primitive immune system 
(Janeway, 1989). 
Numerous studies (in rats, mice and humans) have revealed that this natural 
killer activity is typically associated with large granular lymphocytes (LGLs), 
containing a high cytoplasm to nuclear ratio, distinct azurophilic granules (Luini et al, 
1981), and a kidney-shaped nucleus (O'Shea & Ortaldo, 1992). However, 
heterogeneity does exist amongst NK cell populations, both morphologically and 
fijnctionally (Hercend et al, 1983), and this is likely to represent different stages of 
N K cell differentiation/activation. (Allavena & Ortaldo, 1984). Thus, the reactivity 
of an entire N K population is likely to represent the sum of the reactivities o f all the 
different N K populations present. 
Characterisation o f the cell surface antigens has demonstrated that N K cells 
are phenotypically distinct from both B- and T- cells, since they express neither 
surface immunoglobulin nor T cell receptor / CD3 complex. Instead, they are 
characterised by the presence of both CD 16 (immunoglobulin Fc receptor, FcyRIII) 
and CD56 (Leu-19), although both CD 16^ CD56" and CD 16" CD56^ variants have 
been observed. Other cell surface antigens observed include the myelomonocytic-
related marker C D l 1, and the T-cell-related markers CD2 and CDS, all of which may 
be important in target recognition and the subsequent activation of the N K cell. 
Natural Killer cells can thus be defined as follows (Taken from O'Shea & Ortaldo, 
1992): 
"NK cells are CD3' T cell receptor (alpha/beta, gamma/delta)" large 
granular lymphocytes. They commonly express markers such as CD 16 
and NKH-1 (Leu 19) in humans and N K - l , l / N K - 2 . 1 in mice. They 
mediate cytolytic reactions that do not require expression of Class I or 
Class I I M H C molecules on the target cells. 
Certain T lymphocytes which are either alpha/beta'' or gamma/delta^ may 
express, particularly upon activation, a cytolytic activity that resembles 
that o f N K cells. These T lymphocytes should not be termed N K cells. 
They could be termed either T lymphocytes displaying 'NK-like' activity 
or 'non-MHC requiring' cytolysis." 
A large proportion o f the N K activity is found in peripheral blood, where N K 
cells account for approximately 10 - 15 % of the lymphocyte population. However, 
LGLs (and the associated cytotoxicity) have also been observed in the lungs, liver 
and spleen (where they are located predominantly in the red pulp - Witte et al, 1989), 
and to a lesser extent in the bone marrow and lymph nodes. It is interesting that 
different lymphoid organs contain phenotypically different N K cell subsets (Witte et 
al, 1989), but that they are similarly distributed in a number o f animal species, since 
this provides clues to a possible differentiation pathway. 
N K cells are believed to have several important roles in the immune system, 
including the regulation of haematopoiesis, an involvement in transplantation 
(possibly exerting anti-graft effects early after transplantation, but more importantly, 
providing protection against malignancies and opportunistic infections until B- and T 
- cell fijnctions have completely recovered - Hogan in "The Natural Killer Cell" 
Chapter 5), combating bacterial infection (they are attracted by bacterial products 
to the site o f inflammation, where they can both directly phagocytose the bacterial 
cell, and produce a variety o f cytokines which act on other effector cells to mediate 
the inflammatory response), combating viral infection, and possessing strong 
tumouricidal activity. 
A great deal o f research is currently taking place into these last two fijnctions 
since tumours and viruses (especially the human immunodeficiency virus (HIV) which 
causes AIDS (acquired immunodeficiency syndrome)) pose an enormous threat to the 
health o f society. It is possible that N K lysis of virally-infected cells is mediated via 
several mechanisms :- N K cells are first activated by, and proliferate to, either viral 
glycoproteins, cytokines or virus-induced type 1 interferon (INF a,P), they may then 
undergo direct cell-mediated lysis, or secrete cytokines which either inhibit virus 
replication or activate other mechanisms of natural immunity. It is fiarther possible 
that, in the later stages o f infection, NK cells can lyse virally-infected cells which have 
been coated with antibody, via the ADCC (Antibody - dependent cellular 
cytotoxicity) mechanism. (Welsh & Vargas-Cortes, in "The Natural Killer Cell" 
Chapter 4). Further research is thus necessary to assess the relevant contribution of 
each o f these mechanisms, and hence which could be exploited for the highest 
therapeutic benefit. 
1.2 Origin of N K cells - developmental relationship 
between N K and T Cells. 
Numerous studies over the last two decades have demonstrated that N K - and 
T-cells share a number o f common features, suggesting that they may be derived 
from a common progenitor. Furthermore, since N K cells are involved in the two 
earliest phases o f mammalian host defence against infection (innate resistance and the 
early interferon-inducible phase that is largely antigen non-specific), while T-cells are 
involved in the last, highly antigen-specific phase that generates immunological 
memory, it is also likely that cytotoxic T-cells evolved from N K cells, probably 
through the acquisition o f a clonally-distributed receptor (Janeway, 1989). Indirect 
evidence for the developmental relationship between NK- and T-cells comes from 
studies in immunodeficient patients: one patient was observed to have normal 
myeloid and B-cells but no T- or NK-cells (suggesting that there is a common T-cell-
NK-cell progenitor distinct from totipotent lymphoid progenitors), while another 
patient had normal T- and B-cells but no N K cells, suggesting that at least the later 
stages o f N K - and T-cell differentiation are separate from each other (Lanier, Spits et 
al 1992). 
More direct evidence has come from the study o f the cell surface markers 
present on T- and NK-cells, both fetal and adult. The most distinguishing feature 
between the two cell types is that T-cells express a T-cell receptor (either ap or y5, 
but usually the former), while N K cells do not - otherwise their expression o f surface 
antigens is remarkably similar (providing fUrther evidence that they are related). N K 
cells are usually classed as membrane CD3' CD56^, and T cells as either mCDS"" 
CD5* CD4^ CD8" or mCD3^ CD5^ CD4" CD8^ Both cells express CD2, CD7, 
C D l 8 , CD 16, CD29, CD38, CD44 and CD45RA, and both lose expression of CD34 
(which is considered to be a marker o f immature progenitor cells o f several lineages) 
as they mature. 
Although N K cells do not express the CD3 complex (consisting o f y, 5, E and 
C, chains), which is associated with the TCR and is involved in signal transduction in 
T-cells, it has been shown that they may express certain of the individual subunits. 
Lanier, Chang et al (1992) have demonstrated that resting adult N K cells, fi-eshly 
isolated from human peripheral blood, contain CD3s transcripts in their cytoplasm, 
but not CD3 y or 5. In-vitro activation o f these N K cells causes the expression o f the 
CD38 mRNA into CD38 proteins which, seemingly, are restricted to the cytoplasm. 
Since there are no y or 5 proteins present, there is no formation of a CD3 complex. 
In comparison, fetal N K clones from human liver express both CD3s and CD35 (and 
in some cases CD3y as well) in the cytoplasm, and are therefore capable of forming 
CD35,s complexes (and low levels of CD3y,8 in those clones expressing CD3y). 
However, these complexes are again restricted to the cytoplasm, indicating that they 
are unable to be transported to the cell surface. Although CD3C has been detected 
on the surface o f peripheral blood N K cells (Anderson et al, 1989) and has been 
found to be identical to the T cell CDliC, (Moingeon et al, 1990), there has been no 
evidence o f CD3s,(!^ complexes in either fetal or adult NK clones (Lanier, Chang et 
al, 1992). 
It is not yet known whether the fetal CD3y, 5, s"" and the adult CD38'" N K 
cells represent different N K cell subsets (the latter replacing the former after birth), or 
whether they represent the developmental progression of a single cell subset. (In this 
case, it would imply that CD3 expression is down-regulated as the N K cell 
differentiates, possibly due to the inavailability of a TCR heterodimer for it to 
combine with). The ftinction o f these cytoplasmic CD3 subunits is also unknown ( i f 
they even have a fUnction at all - it may be that they are simply inadvertently 
expressed by a promiscuous transcriptional factor during the activation o f the N K 
cell). 
These results suggest, therefore, that the T-cell-NK-cell progenitor may 
express CD3y 5, s and C subunits, and that their fate depends on the signals that they 
receive. For example, those cells destined for the T-lineage pathway presumably 
receive signals for homing to the thymus and rearrangement of TCR genes. On entry 
to the thymus, these cells proliferate extensively, rearrange their TCR genes to 
generate a vast diversity of TCR molecules, and begin to express low levels of both 
CD4 and CDS. They then undergo education via a process o f positive and negative 
selection to ensure that only self-tolerant cells can exit to the periphery. This 
selection involves the close interaction o f thymocytes with the non-lymphoid cells of 
the thymus, including macrophages, epithelial cells and dendritic cells, which express 
high levels o f self M H C proteins (both class I and class I I ) . Thymocytes whose 
TCRs recognise and respond to self M H C are positively selected to survive, since 
these are potentially useful, but those which respond too strongly (by recognition of 
both the self M H C and the self peptide it is presenting) are destroyed (negative 
selection) because they are harmfial. Any thymocyte that does not recognise self 
M H C is useless and dies naturally within about three days. Depending on whether 
the thymocyte TCR binds to a class 1 or class I I MHC molecule, the selected cell will 
up-regulate CDS expression and become a cytotoxic T-cell, or up-regulate CD4 
expression and become a helper T-cell respectively (von Boehmer & Kisielow, 1991). 
Lanier et a/ (1992) have suggested that T-cell-NK-cell progenitor cells (in the 
fetal liver or bone marrow) that fail to receive such signals, or that lack a thymic 
microenvironment, wi l l , by default, proceed along the N K cell developmental 
pathway, with the resultant expression o f CD56, loss o f CD34, and acquisition of 
cytolytic activity. However, it is also possible that positive signals are necessary for 
the progenitor cells to enter the N K differentiation pathway. 
Interestingly, fetal N K cells have been shown to be capable of most o f the 
fijnctions recognised in mature N K cells (Lanier, Spits et al, 1992), including non-
M H C restricted cytolysis, antibody dependent cellular cytototoxicity, response to 
interleukin-2, and production o f regulatory cytokines (including gamma-interferon 
and tumour necrosis factor a) . This would indicate that immunocompetent N K cells 
develop before T-cells during fetal ontogeny (which is consistent with their provision 
o f an early, first line form of defence). 
Although N K cells have been observed at a very low frequency in the thymus 
(<0.1% o f cells, with the phenotype mCD3s- N K l . T in mice, and mCD38' CD56^ 
CD 16*'" in humans), they develop normally in athymic nude mice, and thus represent 
a thymus-independent lymphoid lineage. Consequently, it is postulated that the T-
cell-NK-cell progenitor differentiates into T-cells in a thymic environment, and N K 
cells in an extrathymic environment. 
Evidence for this includes work by Poggi et al (1993) who have demonstrated 
that triple negative CD3" CD4' CDS" embryonic liver cells (at 6 - 8 weeks o f 
gestation) can be induced to differentiate into either T- or N K cells (expressing 
functional receptor molecules) depending on the culture conditions used. When 
cultured with phytohaemagglutinin (PHA) and recombinant interleukin 2 (rIL-2), 
they gave rise to CD3* lymphocytes expressing either ap or y5 TCR, but when 
cultured with irradiated H9 cells and rIL-2, they gave rise to CD3" CD 16* CD56* 
cells with strong cytolytic activity. Although the results do not determine whether T-
and N K cells are derived from the same precursor, they do demonstrate that the fetal 
liver does contain T-cell / N K cell progenitors, and that there could be an extrathymic 
developmental pathway. 
Further evidence was provided by Rodewald et al (see Lanier, Spits et al, 
1992) who demonstrated that, in mice, day 14 CD 16* (FcyRIII) fetal thymocytes 
differentiated into mature T-cells when injected intrathymically, but differentiated into 
N K l . l * N K cells with N K and ADCC activity when injected intravenously and 
treated with IL-2. However, although the results suggest a common CD 16* T-cell-
NK-cell progenitor, it is not proven. (Interestingly, when mature adult mouse N K 
cells were injected intrathymically, they were unable to generate a T-cell lineage, 
implying that committed N K cells are void o f any T-cell progenitor activity). 
Similarly, Brooks et al (1993) have shown that the majority of day 14 fetal 
thymocytes from mice can differentiate into lymphocytes with many characteristics o f 
mature N K cells i f exposed briefly to IL-4 + PMA (phorbol myristate acetate) then 
treated with IL-2 . Consequently, these cultured fetal thymocytes have the phenotype 
I g , Thyr, CD2-, CD3-, CD4-, CDS", CDS", CD44", CD45^ CD45R\ L y 6 A \ HSA", 
M H C - r , M H C - i r , F4/80", N K l . T , asialo-GMr, express powerful cytolytic activity 
against NK-sensitive targets, and secrete various cytokines. (Likewise, studies in 
humans have shown that treatment of fresh thymocytes with rIL-2 results in the 
induction o f N K activity, and that this activity can be correlated with the appearance 
o f the N K H l antigen on a sub-population of cells - Michon et a/, 1988). In addition, 
and perhaps somewhat surprisingly, it has also been observed (Brooks et al, 1983) 
that mature cytotoxic lymphocytes are capable o f non-specific cytolytic activity, 
including perforin-mediated cytotoxicity, after stimulation with interleukin-2 
(Milanese et al, 1986), In fact, it seems that they have differentiated into cells 
indistinguishable from splenic N K cells, exhibiting an increase in size and granularity, 
the loss o f antigen-specific cytolytic activity, and a change in the cell surface 
molecules. It is therefore proposed that N K cells belong to the T-cell lineage, and in 
particular, may be very closely related to cytotoxic cells. 
All this evidence (together with the study o f lymphocyte phenotypes in both 
the fetal and adult thymus) has led Lanier, Spits et al (1992) to propose the following 
hypothetical scheme for the differentiation of T and N K cells (see Figure 1.1). From 
this scheme, it would appear that the very early stages of lymphocyte development 
are identical, and that the most likely phenotype for a T-cell-NK-cell progenitor is 
CD2' CD3' CD4' CDS" CDS" CD7^ CD19" CD33" CD34^ CD56". At this point the 
two pathways then diverge and the progenitor is committed to the T or N K cell 
lineage, differentiating in the thymus or extrathymically respectively. 
More recently, Sanchez et al (1994) have confirmed this T cell / N K cell 
relationship by identifying a progenitor in the human thymus which is capable of 
giving rise to both T and N K cell lineages. This progenitor is a CD34* Triple 
Negative ( [TN] CD3", CD4", CD8") thymocyte which has been shown to have both a 
high N K cell clonogenic capacity, and the ability to generate both mature CD3* T 
cells and CD56* CD3' N K cells in murine fetal thymic organ culture (mFTOC). I t is 
hypothesised that in the thymic microenvironment, the majority o f these progenitors 
wil l gradually lose their CD34 and acquire CD2, CD5, CD28, CD38, and C D l , at 
which point they will have become irreversibly committed to the T cell lineage (as in 
Figure 1.1). However, a small percentage will differentiate into mature N K cells, 
indicating that although NK cells represent a thymic-independent cell line, they are 
capable o f developing inside the thymus too. As yet, the immunological significance 
of this is unknown. 
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Figure 1.1 : Hypothetical scheme of NK cell and T cell differentiation (Taken from 
Lanier, Spits et al, 1992) 
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1.3 N K Cell specificity - molecular events involved in 
target recognition and biochemical activation. 
NK cells are known to recognise and lyse a variety of tumour and virally-
infected cells, but the mechanism by which they do this is not yet fully elucidated. 
Since physical contact between the natural killer cell and it's target is necessary for 
killing to take place, it seems likely that lysis is mediated through specific interactions 
between cell surface molecules expressed on the two cell types. In other words, 
there are believed to be receptors on the surface of NK cells, distinct from both 
surface immunoglobulin on B cells and T cell receptors on T cells, which interact 
with ligands on target cells to regulate killing. Recent studies have proposed several 
potential receptors (many of which may enhance adhesion), and have suggested that 
there may be structures involved in both activation and inhibition of the cytolytic 
activity. 
One of the earliest-discovered mechanisms by which NK cells act is that of 
antibody-dependent cellular cytotoxicity, or ADCC, whereby effector cells are able to 
lyse immunoglobulin (Ig) - coated targets through their expression of a receptor for 
the constant (Fc) portion of the immunoglobulin. Such a receptor has been identified 
in NK cells - it is a transmembrane, phosphatidylinositol glycan-linked molecule 
(Simmons & Seed, 1988) of approximately 50 - 70 kDa (Lanier, Ruitenberg & 
Phillips, 1988). It has been shown to bind IgG complexes with low affmity and has 
been termed FCyRIII or CD 16. (O'Shea & Ortaldo, 1992). The discovery that it is 
co-associated with the CD3C, homodimer on the membrane of human NK cells 
(Lanier et al, 1989; Anderson et a/, 1990), and the knowledge that CD3C, is involved 
in signal transduction after binding of the TCR in T cells, has led to the suggestion 
that CD 16 is a fijnctional NK membrane receptor which allows activation of the NK 
cell lytic pathway through the CD3C,. 
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Similarly, CD2 is also thought to fijnction as an adhesion/activation molecule 
in NK cells (Scott et al, 1989). It is a 50 - 58 kDa glycoprotein belonging to the Ig 
gene superfamily, and is believed to enhance adhesion by binding to it's ligand LFA3 
(another adhesion molecule, expressed on several cell types). Furthermore, 
redirected lysis assays have demonstrated that it has signal transducing functions, and 
may also operate via CD3^ (Anderson et al, 1989). However, it is unlikely that 
either of these molecules (CD 16 or CD2) play a crucial role in natural killing, since 
NK cells which lack them still exhibit cytotoxicity (Nagler et al, 1989). 
Other interactions which may promote adhesion include LFAl (CDlla - an 
integrin gene superfamily member) on the NK cell with ICAM-1 (a 90 kDa 
transmembrane protein with homology to neural cell adhesion molecule NCAM) on 
the target cell, and CD56 (a 175 - 185 kDa glycoprotein that has been identified as an 
isoform of NCAM - Lanier, Testi et al, 1989) on the NK cell with it's ligand on the 
target cell. 
However, there are other putative natural killer cell receptors (NKR) which 
are potentially more important, and these have been discussed in several reviews 
(Hoferc;/a/, 1992; Yokoyama, 1993 ; Yokoyama & Seaman, 1993). One of these is 
the rodent NKR-Pl antigen, which is believed to be responsible for NK cell 
activation in spontaneous cytotoxicity. NKR-Pl is a 60 kDa, disulphide-linked 
homodimer which is expressed by all rat NK cells, possibly in multiple, related forms. 
It is a type I I integral membrane protein with an extracellular carboxy terminal and a 
single transmembrane domain, and has significant homology with members of the C-
type lectin superfamily (Giorda et al, 1990). Since several members of this 
superfamily (which are frequently cell surface receptors) bind to specific 
carbohydrates (in a Ca^ -^dependent manner), it is suggested that the NKR-Pl ligand 
is also a carbohydrate, although as yet no such ligand has been identified. (Given that 
NKR-Pl belongs to a family of homologous genes, with each NK cell expressing 
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more than one isoform, it is possible that the ligand is also polymorphic, or that there 
is a different ligand for each isoform). 
Evidence that NKR-Pl is an activation receptor comes from redirected lysis 
assays (where a mAb binds to the effector cell via it's F(ab) regions, and to the target 
cell via it's Fc region, thus bridging the two cells and stimulating the receptor) and 
from direct stimulation of the NK cell with a mAb that recognises NKR-Pl (mAb 
3.2.3 - Chambers et al, 1989). Both of these result in tyrosine phosphorylation, the 
activation of phosphoinositide turnover, an increase in intracellular calcium, and the 
resultant degranulation by the NK cell, all of which are biochemical events observed 
when an NK cell contacts their natural targets. Similar studies have been made in 
both mice and humans, and it has been found that NK cells in these species also 
express activation receptors, termed N K l . l and NKG2 respectively. These display 
similar characteristics to NKR-Pl, and similarly exist in several isoforms. 
Another receptor family identified on NK cells, that shows homology to the 
C-type lectin supergene family, is represented by the mouse Ly-49, a dimeric 
glycoprotein (Yokoyama & Seaman, 1993). Again this is a type I I integral 
membrane protein with an extracellular carboxy domain, and is encoded by a member 
of a family of highly-related genes, but in this instance, the receptor is believed to act 
as an inhibitor of NK cell cytolytic activity since NK cells expressing Ly-49 are 
unable to lyse normally-susceptible tumour targets. This has been correlated with the 
observation that there is an inverse relationship between MHC class I expression on 
target cells and their susceptibility to NK cell lysis, to suggest that the ligand for Ly-
49 is MHC class I (Hofer et al, 1992). 
Although NK cell-mediated lysis is known to be non-MHC restricted, several 
groups have demonstrated that mutant target cell lines which are deficient in MHC 
class I expression are more susceptible to NK cell-mediated lysis than the parental 
strains. For example, H-2 deficient variants of the RBL-5 lymphoma (which is 
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normally NK-resistant and highly malignant) have severely reduced tumourigenicity 
and are NK-sensitive (Karre et al, 1986). Furthermore, numerous studies have 
shown that reconstitution of MHC class I expression, through various molecular 
techniques, results in the restoration of NK-resistance (Yokoyama & Seaman, 1993; 
Ljunggren & Karre, 1990). This effect is, however, quantitative, and there is a 
minimum level of MHC class I expression necessary for protection against lysis to be 
provided (Karre et al, 1986; Ljunggren & Karre, 1990; Storkus et al, 1989). 
Two mechanisms have been proposed to account for the inhibitory effect of 
MHC class I on NK cell activity (Ljunggren & Karre, 1990). The first is that the 
MHC antigen 'masks' the normal stimulatory signal on the target cell, such that 
recognition and activation is blocked in the presence of MHC (thus removal of MHC 
allows lysis to occur), and the second is that there is a receptor on the NK cell which 
specifically recognises the MHC antigen and relays a 'negative' signal into the cell. 
Various studies have suggested that the latter model is more likely. 
It is postulated that Ly-49 represents the receptor family involved in 
'recognising' the presence/absence of MHC class I molecules, since Ly-49^ cells do 
not lyse H-2'' and H-2'' targets, but Ly-49" cells do. In particular, it is thought that 
Ly-49 interacts with the al/a2 domains of the MHC molecule (since it is these 
domains that have been shown to provide the 'protective' Sanction against natural 
killing - Storkus et al, 1989), suggesting that the peptide-binding cleft may be 
involved (Chadwick et al, 1992; Storkus et al, 1992), and ftirther, that the MHC 
haplotype of the target cell is involved in the specificity. This inhibitory influence of 
the Ly-49/MHC class I interaction seems to be dominant over all stimulatory signals, 
allowing a tolerance to self cells. 
The genes encoding both Ly-49 and NKR-Pl have been characterised, and 
have been found to represent gene families that are genetically linked (Yokoyama & 
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Seaman, 1993). In mice they have been mapped to chromosome 6, and in humans to 
chromosome 12, and in both cases are separated by approximately 0.4 centiMorgans 
(about 500kb). This genetic region has been termed the NK gene complex (NKC), 
and is predicted to encode a number of related genes of varying homology, all of 
which may be fijnctionally important in NK cell activity. Consequently, different NK 
cells may express different combinations of these various receptors and thus may 
exhibit different target specificity, which would account for the observed 
heterogeneity in NK cell populations. 
Irrelevant of which of these receptors plays the most important role in natural 
killing, the ultimate consequence of engagement of a stimulatory receptor must be the 
triggering of the cytolytic machinery, with secretion of granule contents (such as 
serine esterases), target lysis, and production/secretion of regulatory cytokines 
(which may involve alteration of gene expression). However, the biochemical steps 
leading to these events are, as yet, only poorly understood. 
In comparison with activation of T cells through the TCR (which is likely to 
be analogous to activation of NK cells through the putative NKR), it is believed that 
transmembrane signalling in NK cells occurs through phosphoinositide turnover 
(Chow & Jondal, 1990), with generation of the second messengers inositol-1,4,5-
triphosphate (IP?) and sn-l,2-diacylglycerol (DG) (Windebank et al, 1988). IP3 then 
mobilises intracellular Ca^ ^ from endoplasmic reticulum stores, while DG activates 
protein kinase C (PKC - a major intracellular serine/threonine kinase), both resulting 
in cell activation (Leibson et al, 1990). In addition, it is thought that this second 
messenger activation system may be fiarther regulated by another second messenger 
system such as cAMP (Windebank et al, 1988). 
Numerous studies (reviewed in O'Shea & Ortaldo, 1992) have shown that 
exposure of NK cells to tumour targets or antibody-coated targets, or direct 
stimulation of FcyRIII, results in an increase of phosphoinositide (PI) turnover and a 
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rise in the intracellular calcium levels (Cassatella et al, 1989), supporting the 
suggestion that the NKR is coupled to PI hydrolysis and PKC activation. This 
increase in calcium levels (caused by both intracellular release and extracellular 
influx) is fijrther believed to be critical in the production of cytokines (such as IFNy 
and TNF) which play an important role in part of the natural killer cells mode of 
action (Cassatella et al, 1989). (Interestingly, virally-infected cells do not induce PI 
turnover or calcium release, which suggests that these targets may activate a different 
biochemical pathway, but, as yet, this is unknown). However, there may also exist 
some sort of autoregulation by PKC, such that PI turnover coupled to one type of 
surface receptor may be inhibited (allowing 'desensitisation' to prolonged target 
exposure), without blocking the second messenger cascade induced by engagement 
of a different membrane receptor (Leibson et al, 1990). 
In addition to the serine/threonine kinase (PKC), it appears that signalling 
may also occur via a protein tyrosine kinase (PTK). O'Shea et al (1991) have 
demonstrated that stimulation of NK cells via FcyRIII (either with antibody-coated 
cells or anti-FcyRIII mAb) induces phosphorylation of the C chain, a known substrate 
of PTK in T cells. Since C has been shown to be physically associated with FcyRIII 
(Lanier et al, 1989; Anderson et al, 1990), this would suggest that FcyRIII is 
therefore coupled to a PTK, and has a similar signalling mechanism to that observed 
in T cells via the TCR and the Ick and fyn PTKs. (NK cells have, in fact, been shown 
to express Ick and fgr PTKs - see O'Shea et al, 1991). 
It is feasible that signalling in NK cells occurs via a cascade of kinases, 
including both protein tyrosine kinases and serine/threonine kinases. For example, 
NK cells possess an IL-2 receptor (of which the p75 glycoprotein is the structure 
primarily responsible for activation by IL-2 - Phillips et al, 1989; Tsudo et al, 1987) 
which appears to be coupled to a PTK, but whose function is also blocked by PKC 
inhibitors. (Stimulation of NK cells by IL-2 significantly broadens the range of 
targets that the cell can lyse, in a phenomenon known as Lymphokine Activated 
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Killing or LAK, Mason et al, 1990. Furthermore, IL-2-stimulation appears to act 
synergistically with stimulation of FcyRIII (CD 16) to induce optimum levels of 
activation antigens on the cell surface, and promote optimum NK cell proliferation -
Harris 6^/fl/, 1989). 
There are clearly many interactions and biochemical events involved in the 
activation of NK cell cytolytic activity (some of which are schematised in Figure 1.2), 
and much information still to be obtained about them. Since natural killer cells 
potentially provide a highly important fianction in tumour and viral immunity, it is 
appropriate that a thorough and detailed investigation into their mode of action is 
made, particularly into their molecular interactions, as this may lead to crucial 
therapeutic developments. 
Figure L 2 : Schematic representation of the postulated molecular and biochemical 
events occurring between an NK cell and it's target. (Taken from O'Shea & Ortaldo, 
1992) 
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1.4 Phylogeny of NK-like cells 
Studies on other vertebrates have further suggested that there is a common 
evolutionary origin between NK and Tc cells, since various common features have 
been identified in different species. For example, Gobel et al (1994) have 
characterised a candidate NK cell in chickens. These cells are splenic granular 
lymphocytes which are both thymus- and bursa- independent. They exhibit no T cell 
receptor gene rearrangements, nor surface expression of either TCR or CD3, 
although they do express cytoplasmic CD3 (similar to that observed in mammalian 
NK cells). Since these chicken LGLs (large granular lymphocytes) are also able to 
bind chicken IgG, it is further possible that they possess an FcyRIII homologue, 
which may allow them to perform ADCC. Avian NK cells also express CDS markers 
(in the form of aa homodimers) and IL-2 receptors (especially following culture in 
IL-2-rich supernatant), but do not express CD4, MHC class I I or immunoglobulin. 
Additionally, Gobel et al (1994) have demonstrated that these NK-like cells exhibit 
spontaneous cytotoxicity against an established NK cell tumour target, all of which 
suggests that they are the mammalian NK homologue. 
In fish, Evans et al (1988) have identified a monoclonal antibody (5C6) which 
binds to a receptor on the surface of fish nonspecific cytotoxic cells (NCC -
analogous to human natural killer cells), inhibiting their ability to lyse target B-
lymphoblastoid cells (by blocking recognition between the effector and it's target). It 
is probable that the mAb 5C6 recognises a receptor involved in the activation of fish 
NK cells, inducing increased levels of Ca'^ *, increased expression of membrane 
receptors, and increased cytotoxicity (Evans et al, 1990), similar to that observed in 
mammalian NK cells. Furthermore, NK-like cells in teleost fish have been shown to 
lyse human cell lines sensitive to human NK cell lysis (Harris et al, 1991), and that 
both human and fish killing of these lines can be blocked by mAb 5C6, suggesting 
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that fish and human NK cells may use similar evolutionarily conserved cell surface 
receptors to recognise the same target antigens. 
In amphibians (which occupy a crucial position in the evolution of both 
modern birds and mammals), natural killer cell activity against tumours has been 
demonstrated in several anuran species, in both the spleen, peripheral blood and bone 
marrow (Ghoneum et al, 1990). These anuran NK cells were found to be similar to 
mammalian NK cells in both their cell structure and intracellular changes after binding 
to their target, and in their response to various inhibitory drugs. Antibody-dependent 
cellular cytotoxicity (one of the characterising features of NK cells, and possibly one 
of the oldest methods whereby vertebrates reject non-self tissue) has also been 
observed in Xenopus, against antibody-coated chicken red blood cells (Jurd & 
Doritis, 1977). Horton, Horton & Varley (1989) have demonstrated cytotoxicity of 
adult Xenopiis splenocytes against MHC class I-negative tadpole target cells, which 
could represent NK cell-mediated lysis due to lack of MHC expression, eg. via an Ly-
49 homologue. (However, since these larvae do express MHC class I I , such killing 
may be caused by T cell recognition of class I I instead.) 
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1.5 The Immunobiology of Xenopus 
Numerous immunobiological studies have established that the South African 
clawed toad, Xenopus laevis, is an ideal animal model for investigating vertebrate 
immunology (Horton, 1994). It is an entirely aquatic anuran amphibian which is easy 
to maintain and breed in the laboratory, and, since it's larvae are free-living and thus 
free of maternal influences, is easily experimentally manipulated. For example, 
thymectomy can be performed at an early developmental stage, which is effective at 
eliminating T cells (Gravenor et al, 1995). Such thymectomised (Tx) Xenopus are of 
obvious relevance to studies designed to probe NK cells at this level of evolution. 
Xenopus is particularly valuable because of the remarkable immunological 
resemblance it has to higher vertebrates, possessing all the basic features of the 
sophisticated immune system found in mammals. For example, Xenopus possesses 
several lymphoid organs including a thymus (with a cytoarchitecture that resembles 
that of other jawed vertebrates), spleen (differentiated into red and white pulp), gut 
associated lymphoid tissue (GALT), liver and kidney (Plytycz & Bigaj, 1983., 
Katagiri & Tochinai, 1987). There is a division of lymphocytes into B and T cells 
(Manning, Donnelly & Cohen, 1976) (including helper and cytotoxic functions), and 
there are three classes of immunoglobulins - IgM, IgY and IgX, analogous to the 
mammalian IgM, IgG and IgA respectively. Xenopus is also the most primitive 
vertebrate to have a defined major histocompatibility complex (MHC), known as the 
XLA {Xenopus leucocyte-associated antigens), which encodes class I , class I I , and 
class I I I - like molecules. Furthermore, in-depth analysis of the Xenopus immune 
system is facilitated by the availability of genetically defined strains, isogenic clones, 
labelled cellular markers, and an increasing number of monoclonal antibodies to 
Xenopus cell surface markers (Horton et al, 1995; Du Pasquier, Schwager & Flajnik, 
1989). 
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With respect to studying natural killer cell activity, anuran amphibians are 
particularly usefiji since they are known to develop both benign and malignant 
tumours (sometimes viral-associated), which, as already stated, represent one of the 
major targets of NK cells. Moreover, their response to chemical carcinogens is 
analogous to that in mammals, and the tumours are generally similar to those found in 
other vertebrates (Anver, 1992), such that they provide a usefiil comparative model 
for the tumouricidal activity of NK cells. 
The occurrence of a spontaneous lymphoid tumour in the thymus of a 
Xenopus male of the inbred family ff in Basel (Du Pasquier & Robert, 1992), and the 
subsequent characterisation of several Xenopus thymus tumour cell lines (Robert, 
Giuet & Du Pasquier, 1994) has provided appropriate target cells on which such 
studies can be made. Certain Xenopus tumour cells (eg. the ff-2 and B3B7 cells - both 
derived from ff inbred Xenopus) are unable to survive i f transplanted to 
histocompatible control or allogeneic adults, even after day 20 larval thymectomy. 
However, the same tumours could survive if transplanted to histocompatible (ff) 
larvae. In contrast, tumours (eg. 15/0) derived form LG15 clonal animals are able to 
survive in LG15 adults as well as in LG15 larval hosts, but fail to survive in ff 
Xenopus hosts (Robert, Guiet & Du Pasquier, 1994). Since the LGI5-derived 
tumour cells, and also the B3B7 cells, fail to express MHC proteins, their rejection by 
certain hosts could well be effected by NK-like cells against non-MHC-encoded 
target antigens. Fortunately, now that these tumour cell lines are established in our 
laboratory, the question of whether NK-like activity is shown towards these cells can 
be tested experimentally by in vitro cytolytic assays. 
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Chapter 2 
Cellular Investigation into the 
Proliferative Responses and Cytotoxicity 
exhibited by Xenopus Splenocytes, and 
their Enrichment by Cell Separation 
Techniques 
2.1 Introduction 
One of the defining characteristics of mammalian natural killer cells is that 
they are able to spontaneously lyse certain tumour cell targets without prior 
sensitisation. The initial goal of this project was, therefore, to identify such 
spontaneous cytotoxicity in Xenopus laevis, to determine whether there were 'natural 
killer' cells present at this level of evolution. These experiments have involved 
chromium release microcytotoxicity assays (following the protocol of Horton et.ai, 
1989) which assess the ability of Xenopus splenocytes to spontaneously lyse ^'Cr-
labelled Xenopus B 3 B 7 tumour targets. Secondly, since IL-2 is known to activate 
mammalian and avian NK cells, and increase the range of targets that are susceptible 
to NK lysis, in a phenomenon known as Lymphokine Activated Killing (or LAK), a 
fijrther goal of the project was to investigate whether such a cytokine-enhanced 
killing phenomenon occurred in Xenopus. LAK activity has been explored following 
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in vitro stimulation of Xenopus splenocytes with putative Xenopus IL-2. Mammalian 
IL-2 cannot be used since there is evidence that it fails to stimulate Xenopus 
lymphocytes in vitro (Watkins & Cohen, 1987). 
In order to achieve these goals, my research began with a series of 
experiments attempting to generate active supernatants from Xenopus splenocytes by 
in vitro stimulation with the T cell mitogen Concanavalin A. Supernatant activity 
was initially assessed in tritiated thymidine (^HTdR) assays using splenocytes or 
splenic lymphoblast targets. Since Xenopus laevis lymphocytes are known to 
produce a 'T-cell-growth-factor' or 'interIeukin-2' when they are stimulated by T cell 
mitogens (Watkins & Cohen, 1987; Haynes & Cohen, 1993), it is likely that the 
proliferative activity observed in these culture supernatants is due to the presence of 
IL-2 in them. Thus, supernatants that were stimulatory in terms of ^HTdR 
incorporation were then tested for their ability to potentiate spontaneous cytotoxicity 
of Xenopus lymphocytes towards ^'Cr-labelled tumour targets. In other words, 
mitogens were being used to generate IL-2-rich supernatants, which could then be 
utilised to treat Xenopus splenocytes in an attempt to increase either their level of 
cytolytic activity or the range of targets that were susceptible to their killing. 
The next phase of the work investigated whether splenocytes could be 
enriched for natural killer cells, such that higher cytolytic activity against tumour cells 
could be observed. Enrichment would also be useftjl for later molecular work, when 
concentrated, purer NK populations were needed for generation of mAbs to NK cell 
surface antigens for characterisation of NK receptors. Cell enrichment is possible 
through the selective removal of other lymphocyte populations, and two techniques 
were attempted in this study. My initial series of experiments concentrated on the 
cell separation technique of "panning" (modified from that described by Wysocki «& 
Sato, 1978, see also Bleicher &. Cohen, 1981). In this method, a sterile plastic petri 
dish is incubated overnight with anti-mouse Ig such that the whole bottom of the dish 
is covered with antibody (see Figure 2.1a). Splenocytes are then incubated with the 
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mouse monoclonal antibody that recognises a cell surface structure specific for the 
cell population to be depleted, such that the target population becomes coated in 
antibody (Figure 2.1b). When these splenocytes are swirled in the petri dish, binding 
takes place between the anti-Ig on the dish and the Ig (mouse mAb) coating the cells, 
thus 'adhering' the target population to the dish base (Figure 2.1c). 'Non mAb-
coated' splenocytes do not bind to the anti-Ig, and remain free in the supernatant as 
'non-adherents'. Consequently, when the supernatant is removed, these non-
adherent cells are removed too (Figure 2. Id), producing a cell population that should 
be free of the target cells. (Adherent cells are freed into solution by gently scraping 
them from the petri dish base with a sterile scraper). 
Following on from these 'panning' experiments, and in an attempt to improve 
upon them, a second method of Xenopus spleen cell enrichment was employed - that 
of magnetic bead cell separation. This technique appeared a novel, and promising, 
approach to enrich for non-T/non-B lymphoid cells. The principles of separation are 
the same as those used in panning, i.e. coating the target cells in the appropriate 
mouse monoclonal antibody (Figure 2.2a), and then binding these to a solid surface 
through the interaction with anti-mouse Ig (Figure 2.2b). However, in this technique, 
the solid surface is a magnetic bead rather than the plastic petri dish. The beads used 
in this study were Dynabeads'® M-450, already coated with sheep anti-mouse IgG. 
MAb-coated splenocytes are mixed with the Dynabeads® and incubated for a 
sufficient length of time to allow binding to occur between the anti-mouse Ig and the 
mouse mAb (Figure 2.2b). To achieve separation, this mix is then placed into a 
'Magnetic Particle Concentrator' (MPC) which has a magnet on one side, such that 
the superparamagnetic beads are attracted to that side, pulling the target cells with 
them (Figure 2.2c). Similar to the panning technique, the supernatant containing the 
non-target cells (the non-adherents) can easily be pipetted off and kept aside as a 
'target-cell-depleted' population. The adherent (or target) cells can be removed from 
the beads either by enzymatic action or overnight culture, but in either case the 
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sample must be placed in the MPC to remove the magnetic beads from the cell 
suspension before the splenocytes can be used in ftirther assays. 
Both techniques can, therefore, be used to produce either a 'pure' population 
of target (mAb-coated) cells (i.e. the adherents), or a mixed population depleted of 
the target cells (i.e. the non-adherents). Given that natural killer cells constitute only 
a small portion of the total lymphocyte population (and thus may prove difficult to 
pull off enough as target cells), it was considered that the more likely technique of 
enriching a cell population for NK cells would be to deplete the splenocyte culture of 
other large populations of cells. This was thus attempted with various monoclonal 
antibodies to both T cells and B cells. Evaluation of the purity of each population, 
and hence how successfial the separation technique had been, was facilitated by the 
spectrum of monoclonal antibodies that are now available to Xenopus lymphocyte 
antigens, and their identification through flow cytometry. Furthermore, having 
separated the various populations, a fijrther goal of the project was to determine the 
cytolytic potential of each cell population, in an attempt to identify the lymphoid 
subset responsible for the cytolytic activity. 
Finally, the information obtained from this study provided a sound and 
thorough basis on which fijrther goals could be set regarding a molecular 
investigation into the fijnction, surface antigens and biochemical activation of natural 
killer cells (see Chapter 3). 
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Figure 2.1 : Diagrammatic Representation of Cell Enrichment by 'Paiming'. 
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Petri dish incubated overnight 
with anti-mouse Ig. 
(b) 
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Cells incubated with mouse 
monoclonal antibody e.g. 8E4 
(anti-Ig). 
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minutes. mAB coated cells bind 
to anti-mouse Ig. Cells not 
coated with mAB do not bind. 
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n u U U 0 
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non-adherents 
Supernatant removed, leaving 
bound 'adherent' B cells behind. 
Adherents can then be gently 
removed into a separate tube. 
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Figure 2.2: Diagrammatic Representation of the Indirect Technique of Cell 
Separation using Magnetic Beads. 
(a) 
A; 
Splenocyte incubated with 
mouse monoclonal antibody 
e.g. 8E4 (anti-Ig). 
(Added in excess to block 
all antigen binding sites 
onto the cell surface). 
(b) 
I I V 
B 
Sheep anti-
mouse IgG 
Magnetic bea 
(dia. = 4.5nm 
Dynabeads® M-450 added 
to Cell Suspension. 
(c) 
Magnet 
Supernatant removed, 
leaving bound 'Adherent' 
cells behind. 
non-adherents 
Magnetic 
Particle 
Concentrator 
Adherents 
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2.2 Materials and Methods 
2.2.1 Animals and Rearing 
Outbred Xenopus laevis were bred in the laboratory and reared at 23 °C ± 1°C 
in dechlorinated water. As soon as embryos developed into tadpoles, and until their 
metamorphosis, they were fed with nettle powder. Toadlets were then initially fed 
with bloodworms but gradually progressed to minced mammalian heart, 
supplemented with pellets (Diet 1, Blades Biologicals). Adults were also fed with 
minced mammalian heart and supplemented with Diet N° 2 pellets. Ages of animals 
used are given in Results section. 
2.2.2 Early Thymectomy 
Xeriopus tadpoles were mainly thymectomised (Tx) at 6-7 days/stage 47-48 
(Nieuwkoop & Faber, 1967), but a few thymectomies were also carried out on 35 
day old / stage 56/7 larvae. All thymectomies were performed by Dr J. D. Horton. 
Thymectomy was performed by electromicrocautery as previously described (Horton 
& Manning, 1972), and the absence of a thymus was checked by dissection of adults 
on killing. 
2.2.3 Preparation of Splenocyte Suspensions 
Animals were over-anaesthetised in MS222 (3-aminobenzoic acid ethyl ester 
[Sigma]) and then sprayed with 70% alcohol. In a laminar air flow hood, their 
spleens were then dissected out using forceps and micro-scissors and placed in a 
small, sterile petri-dish containing 2ml sterile culture medium (see 2.8.1) or panning 
medium (see 2.4). The spleen was then teased apart with a pair of tungsten needles, 
under a dissecting microscope, to break open the organ and release the cells into 
suspension. This suspension was then transferred to a 5ml plastic sterile test tube 
(Falcon), and the petri-dish washed out with a further 2ml medium to collect any 
remaining cells (also added to the tube). After thoroughly mixing, the suspension 
29 
was allowed to settle for 30 - 40 seconds (to remove any large pieces of tissue) 
before transferring the supernatant suspension to a fresh 5ml tube. This was then 
centrifiiged at 300g for 10 minutes, the supernatant discarded, and the pellet 
resuspended in a known volume of culture medium. Lymphocytes were counted 
using a haemocytometer and adjusted to a concentration of 1 million cells per ml. 
2.2.4 Panning (Lymphocyte Enrichment) 
2.2.4.1 Preparation of the panning petri-dish 
An aliquot (30fil of anti-IgG, or 100|al of anti-IgM) of anti-mouse Ig (lOpi 
g/ml. Vector) was added to 10ml of carbonate/bicarbonate buffer (pH 9.8) and 
poured into a petri-dish (Sterilin, 90mm x 15mm). This was gently swirled to ensure 
that the whole of the bottom of the dish was covered, and then it was left overnight 
at4°C 
The buffer was then tipped away, the bottom covered with 'blocking' buffer 
(carbonate/bicarbonate buffer containing 1% BSA), and left to incubate at room 
temperature for 30 minutes. The dish was washed free of blocking buffer by 
thoroughly swirling with 'panning' medium (amphibian phosphate buffered saline 
[APES], 0.1% BSA), and then the bottom was covered with panning medium until 
ready for use. 
2.2.4.2 Panning procedure 
Splenic lymphocytes were resuspended in panning medium for cell counting. 
Approximately 1ml of the lymphocyte suspension was removed into a sterile tube and 
labelled as 'non-panned'. The remainder was then aliquoted into tubes containing ca. 
1ml each (ie. 1x10*^  lymphocytes) and centrifuged at 300g for 10 minutes. 
Supernatants were removed and each pellet was resuspended in 100|j.l of the 
appropriate diluted mouse monoclonal antibody (either of IgM or IgG isotype), then 
left to incubate for 30 minutes at 4°C. 
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Unbound antibody was removed by washing the cells twice with 2ml panning 
medium and centrifliging at 300g for 10 minutes. After the final centrifugation, 
supernatants were discarded and each pellet (of mAb-coated cells) was resuspended 
in 1ml panning medium (If there were less than 6 tubes, extra medium was added to 
the appropriate number of tubes to give a total volume of 6ml). Ensuring that they 
were thoroughly mixed, the cells (usually between 3 and 10 million) were gently 
pipetted onto the anti-mouse Ig-coated dish, swirled, and then left to incubate at 4°C 
for 70 minutes (including a gentle swirl after 40 minutes). 
Non-adherent cells were removed by gently pipetting off" the supernatant into 
a sterile universal (S.H. Scientific), and washing twice by swirling with 4ml panning 
medium (each time removing the washings into the same universal). The adherent 
cells were finally removed by gently scraping the plate with a cell scraper (Greiner) 
and removing the medium into a fresh sterile universal. Again two washes were 
made, scraping each time, and retaining the washings. 
Both universals were then centrifijged at 300g for 10 minutes, the 
supernatants removed and the pellets resuspended in 1ml panning medium. Cells 
were counted using a haemocytometer. 
2.2.4.3 Preparation of panned cells for flow cytometry or tritiated 
thymidine incorporation 
Non-panned, non-adherent and adherent populations were centrifuged (300g, 
10 minutes), the supernatants discarded and the pellets resuspended in bicarbonated 
LI5 culture medium (see 2.6.1) at 1 million leucocytes per ml. Cells were then 
cultured overnight in a 24-well flat-bottomed plate (1ml per well) prior to flow 
cytometry, or used directly in a ^HTdR assay. 
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2.2.5 Magnetic Bead Enrichment of Lymphocytes 
2.2.5.1 Preparation of splenocytes 
Splenic lymphocytes (adjusted to a concentration of 1 million cells per ml in 
culture medium) were dispensed in 1 ml aliquots into sterile tubes and centrifiiged at 
300g for 10 minutes. Supernatants were removed and pellets were resuspended in 
0.5ml of the appropriate monoclonal antibody (made up in sterile amphibian 
phosphate buffered saline [APBS] + 1% fetal calf serum [FCS], pH 7.4 [= 
APBS/FCS]), before being incubated on ice for 45 minutes. (Some control cells 
were set aside, these were resuspended in bicarbonated culture medium and 
transferred to a 24-well, flat-bottomed plate for overnight culture). 
Experimental cells were then washed twice with 1ml APBS/FCS and 
resuspended in 1ml APBS/FCS for counting. After centrifijgation at 300g for 10 
minutes, each pellet was resuspended in 0.5ml APBS/FCS and transferred to a 
separate sterile eppendorf (Greiner). 
2.2.5.2 Preparation of beads 
The immunomagnetic beads used were Dynal® M-450 Sheep anti-mouse IgG 
Dynabeads®. (These are monosized, superparamagnetic, polystyrene beads with 
affinity purified sheep anti-mouse IgG covalently bound to the surface. They are 
supplied as a suspension containing 4x10* beads/ml in PBS pH 7.4 with 0.1% HSA 
and 0.02% NaN^). 
After calculating how many beads would be required for the entire 
experiment, the contents of the stock vial were resuspended, and the appropriate 
volume transferred to a sterile eppendorf. This was placed in the Magnetic Particle 
Concentrator (MPC) for 1 minute and the supernatant removed to remove the 
sodium azide. The beads were then washed twice with 1ml APBS/FCS (removing 
the supernatant in the MPC), resuspended in APBS/FCS at the original volume, and 
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adsorbed with Xerwpvs serum at 1; 20 dilution for 40 minutes on ice (to remove any 
non-specific dinix-Xenopus reactivity). 
2.2.5.3 Adsorption of antibody-coated cells onto beads 
The appropriate volume of washed and pre-adsorbed beads were added to the 
mAb-coated splenocytes in eppendorfs, and rotated at room temperature for 30 
minutes. 0.5ml APBS/FCS was then added to each eppendorf, and the samples were 
thoroughly resuspended before being placed into the MFC for 2 minutes to collect 
the beads and adherent cells ('adherents'). Supernatant cell suspensions were 
transferred to sterile tubes and labelled as 'non-adherents'. Adherent cells and beads 
were washed with 1ml APBS/FCS, the washings being added to the 'non-adherent' 
tubes. The pellet of adherent cells and beads was then resuspended in 1ml 
bicarbonated culture medium. All non-adherent cells were thoroughly resuspended 
and counted, centrifuged at 300g for 10 minutes, and also resuspended in 1ml 
bicarbonated culture medium. All cells (including an aliquot of 'non-beaded' 
splenocytes) were then transferred to a 24-well, flat-bottomed plate for overnight 
culture. 
2.2.5.4 Preparation of cell populations for flow cytometry 
To remove the beads from the positively-selected cells, after overnight culture 
'adherent' samples were transferred to eppendorfs, placed in the MFC for 1 minute, 
and the supernatant suspension removed to tubes. The beads were washed with a 
further 1ml of FACS medium, placed in the MFC, and the supernatant suspension 
added to the appropriate tubes. Non-beaded, 'non-adherent' and 'adherent' splenocyte 
populations were then centrifiaged at 300g for 10 minutes, and cell pellets 
resuspended in 1ml FACS medium for counting. Finally, each sample was adjusted 
to IxlO*" leucocytes/ml in FACS medium, ready for flow cytometry (see 2.6). 
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2.2.5.5 Preparation of cell populations for ''^chromium release assays 
For experiments where a chromium release assay was to be performed on the 
resulting populations, bead-sorted samples were resuspended in 1ml B3B7 tumour 
medium, before being cultured overnight . The next day, some cells were removed 
for flow cytometry (see 2.6), and the rest were serially diluted with B3B7 tumour 
medium in 96-well, round-bottomed plates, to act as effector cells in 6 hour ^'Cr-
release killing assays against B3B7 Xenopus thymus tumour cells(see 2.9). 
2.2.6 Flow Cytometry 
Splenocytes taken directly ex vivo or after overnight culture were washed and 
resuspended at 1x10^ leucocytes/ml in APBS containing 0.1% BSA and 0.1% NaNj 
(FACS medium). 200^1 samples (2x10^ cells) were aliquoted into the appropriate 
wells of a 96-well, round-bottomed plate. The plate was then centriftiged (300g, 10 
minutes) and the supernatant discarded before resuspending each pellet in 50|il of the 
appropriate monoclonal antibody (mAb) and incubating on ice in the dark for 20 
minutes. 
Any unbound antibody was then removed through two cycles of washing with 
FACS medium and the pelleted cells were resuspended in of the secondary 
FITC-conjugated antibody (a 1 in 20 dilution of FITC-labelled F(Ab)2 fraction of 
rabbit anti-mouse immunoglobulin (DAKO), that had previously been adsorbed with 
5% Xetwpi/s serum and centriiliged at 3000g for 5 minutes to remove any debris), 
and incubated on ice in the dark for 20 minutes. This 2° FITC Ab allows the 
visualisation of unconjugated supernatant mAbs and amplifies the signal of purified 
FITC-conjugated mAbs. Cells were then washed twice with FACS medium 
containing mouse serum (1 in 80) to remove any unbound FITC-conjugated anti-
mouse antibody. 
Finally, the cell pellets were resuspended in 50|j.l of the appropriate PE-
conjugated mAb, left on ice in the dark for 20 minutes, and then washed twice with 
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FACS medium. Cells were then resuspended in 400|j,l of FACS medium and left on 
ice in the dark until analysed on the flow cytometer (Coulter XL, MCL). 
(If for any reason the cells needed to be kept at this stage, 400|il of 
formaldehyde fixative (1.0%) was added (final concentration 0.5%) and fixed cells 
stored at 4°C until FACS analysis could be carried out). 
2.2.7Monoclonal Antibodies 
2.2.7.1 mAbs used for F L l ( F I T C ) fluorescence 
All the mAbs (except 2B1) were mouse hybridoma supernatants and therefore 
required FITC-conjugated anti-mouse IgG for visualisation. (The mAbs are IgG 
isotype, except for AM22 and 5C6 which are IgM isotype). 
CT3 - this is directed against the chicken CD3 antigen and should therefore 
not react with Xenopiis cells. It is used as a negative control to 
determine the level of background fluorescence on the FITC channel. 
(Chenet. a!.., 1986). 
8E4:57 - both mAbs recognise surface immunoglobulin M (sIgM) class on 
& 10A9 Xenopus- B cells. (Langeberg et.al., 1987; Hsu & Du Pasquier, 1984). 
ALC - this 'anti-light chain' mix is a mixture of three mAbs (1E9, 409B8, 
mix 13B2) which individually recognise different light chain epitopes of the 
surface immunoglobulin on Xenopus B cells. (Hsu et.al., 1991). 
AM22 - recognises the Xenopiis CD8 equivalent (eg. on cytotoxic T cells). 
(Flajnikc^/f.fl/., 1990). 
2B1 - recognises the At;«o/J7/.v CD5 antigen. (Jurgens e/.a/., 1995). 
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5C6 - putative anti-NK cell mouse mAb raised against catfish NK-like cells 
(Evans ela/., 1988). 
2.2.7.2 mAbs used for F L 2 (PE) fluorescence 
The following mAbs (IgG isotypes, except for F17 which is IgM) were all 
directly conjugated to the phycoerythrin (PE) fluorochrome (prepared and donated 
by Southern Biotechnology, Birmingham, Alabama); -
Ig - mouse IgGi (DAKO). It is used as a negative control to determine the 
level of background fluorescence on the PE channel. 
2B1 - recognises the Alswo/w-v CD5 antigen. (Jurgens e/.a/., 1995). 
F17 - recognises the Xenopris CD8 equivalent (eg. on cytotoxic T cells). 
(Ibrahim c^/.fl/., 1991). 
D8 - recognises surface IgM antigen on Xenopus B cells. (Ibrahim et.al., 
1991). 
2.2.8 In vitro Studies on Splenocytes 
2.2.8.1 Culture medium 
The basic culture medium used was Leibovitz-15 (L-15) medium (+ L-
glutamine) (Gibco), diluted to amphibian osmolarity (220 mosm) with autoclaved 
double distilled water, and supplemented with 0.0 I M HEPES buffer, 2mM 2-
mercaptoethanol (BDH), amphotericin B (2.5|ig/ml) and penicillin (50iu/ml) 
streptomycin (50|ag/ml) sulphate. It was fiirther supplemented with heat inactivated 
(decomplemented) fetal calf serum (FCS; batch 1973, APP) to give a final 
concentration of 1% FCS. All media were prepared aseptically in a laminar air flow 
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hood and were filter-sterilised using 0.22|im filters (Gelman). Medium was stored at 
4°C until ready for use. 0.0IM sodium bicarbonate (Gibco) was added as a buffer 
for cell culture in the CO2 incubator. 
2.2.8.2 Generation of active supernatants using Con A 
Iml splenocyte suspensions (1x10^ lymphocytes per ml) were dispensed into 
each well of a 24-well, flat-bottomed cell culture plate (Greiner). Active 
supernatants were generated by adding freshly-prepared Con A dilutions to each well, 
to give 'in-weir concentrations of l^ig/ml or 2.5[ie/m\. Control supernatants were 
generated using 1ml of splenocytes cultured with 100|il medium instead of mitogen. 
After incubation for 48 hours at 26°C ± 1°C in 5% CO2, cells were gently 
resuspended to remove any clumping, then centrifijged at 300g for 10 minutes. 
Culture supernatants were gently removed by pipetting and transferred to clean tubes 
(Falcon). Both experimental and control supernatants were treated with O.IM a -
methyl mannoside (amm, Sigma) to neutralise any remaining Con A. Finally, these 
supernatants were filtered through 0.2|jm filters (Gelman) and stored in freezing 
cryovials (Nunc) at -20°C until use. 
2.2.8.3 Tritiated thymidine assays 
Splenocytes were adjusted to 1x10^ cells/ml in bicarbonated culture medium, 
then lOO i^l aliquots were dispensed into the appropriate wells of a 96-well, flat-
bottomed tissue culture plate (Greiner). Cultures were set up in triplicate and 
stimulated with either 50|il of active supernatant (ASN) or control supernatant 
(CSN), 10|il of Con A [Sigma] (freshly prepared at various concentrations in 
bicarbonated medium), or 12.5|il of LPS (0.5mg/ml, Sigma). An additional 50|il 
medium was added to the CSN/ASN-stimulated wells, and a control triplicate was set 
up containing lOOpil cells and 100^1 medium. Cells were cultured for 48 hours at 26° 
C ± 1°C (in 5% CO2) before being pulsed with l^Ci tritiated thymidine (^HTdR, 
Amersham, Sp.Act = 5Ci/mmol) per well. After a further 18 hours, cells were 
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harvested, and counted on a Packard scintillation counter which counts the amount of 
tritiated thymidine incorporated into the cells that are in S phase during the pulse 
period. Counts are given as DPM (degenerations per minute). 
Stimulation Indices were calculated as follows: 
Stimulation Index (SI)= DPM Stimulated Cells 
DPM Control Cells (medium-treated) 
2.2.9 Chromium Release Assays 
B3B7 tumour cells were adjusted to a concentration of 1x10^ cells/ml in 
tumour medium and cultured overnight in the presence of ^'chromium at 100|iCi/ml 
(specific activity 350 - 600mCi/mg Cr) to label the tumour cell targets. The next day 
the tumour cells were washed three times in tumour medium, resuspended at a 
concentration of 5x10^ cells/ml in tumour medium, and incubated for Vi - 1 hour in a 
humidified incubator (27°C ± TC, 5%) CO2) to reduce spontaneous release of 
^'chromium. (They were washed again before use). 
lOOfal of these ^'Cr-labelled tumour cell targets (ie. 5x10" cells) were then 
added to 100|il effector cells (control, ASN-treated or separated splenocyte 
populations) serially diluted to give effector: target (E:T) ratios of 40:1 -> 5:1 in 96-
well, round-bottomed plates. The plate was then centrifijged at 300g for 2-3 minutes 
before being incubated in a humidified incubator (27°C ± 1°C, 5% CO2) for 6 hours. 
After this time, the contents of all the wells were gently pipetted and then the 
plate was centrifuged at 300g, for 10 minutes. 100|al supernatant was removed from 
each well, transferred to Titertek tubes, and the amount of''chromium that had been 
released into the supernatant was measured on a Packard gamma counter. 
Minimum levels of spontaneous chromium release were determined by mixing 
100|il labelled tumour targets with 100|j,l B3B7 tumour medium, whilst maximum 
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levels of specific chromium release were determined by mixing lOOpil labelled tumour 
targets with 100|j.l sterile distilled water and freeze-thawing three times. 
Percentage of specific ^'chromium release was calculated according to the following 
equation: 
% specific ^'Cr release = CPM Experimental SN - CPM Minimum SN x 100 
CPM Maximum SN - CPM Minimum SN 
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2.3 Results 
2.3.1 Generation of Active Supernatants by use of Con A 
stimulation 
Note that in all the proliferative assays involving tritiated thymidine, the standard 
deviations were no greater then 11.7%. (Results not shown on individual graphs). 
2.3.1.1 Reactivity to Con A (^HTdR incorporation) 
An initial experiment was set up to determine the optimal Con A dose for 
inducing "^ H thymidine incorporation of Xenopm splenocytes using LI5 culture 
medium (Fig. 2.3). It was found that Con A at 'in-well' concentrations of l|ag/ml and 
2.5|ig/ml were both capable of stimulating splenocytes from control Xenopm, 
although 2.5|j.g/ml produced the highest stimulation. This is in agreement with Ho 
(1992). Stimulation indices varied widely between individual experiments, from 10 
to 77, but on each occasion the highest stimulation index was given by Con A at 2.5|i 
g/ml. The varied SI probably reflects differences in the animals used, maybe in health 
or age, and is unavoidable when using outbred animals. Con A at 'in-well' 
concentrations of 0. l|ig/ml and lO^g/ml both appeared to produce little or no 
splenocyte stimulation 
In order to check the T cell dependence of Con A stimulation, a brief 
investigation of Con A responses in thymectomised Xenopus was carried out. Con A 
is able to minimally stimulate (SI = 4) splenocytes from late-thymectomised (stage 
56/57, 35 days old) Xenopus, but not those from early (stage 48, day 7) 
thymectomised frogs (Fig. 2.4). 
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As a result of the above experiments. Con A at 'in-well' concentrations of 1 
(ig/ml and 2.5\ig/m\ were used to generate 48-hour active supernatants from control 
splenocytes. These supernatants were termed ASN 1 and ASN 2.5 respectively. 
When testing ASNs for their ability to stimulate other splenocytes, it is essential that 
there is no residual Con A from the original production of the ASN, since if Con A 
persists, it would not be certain whether any observed stimulation was due to the 
mitogen itself or a cytokine emerging in the ASN. Consequently, the effectiveness of 
a-methyl-mannoside (a-mm) at removing Con A activity was examined. It was 
found that O.IM a-mm completely abrogates induced thymidine incorporation 
seen with Con A alone (Fig, 2.4). 
2.3.1.2 Proliferative responses to active supernatants 
Con A-derived ASNs generated in this study had various stimulatory 
capabilities, probably reflecting the different extent to which the cells were stimulated 
by the Con A in the original production of the ASN: 
Cells which had been pre-cultured in Con A for 48 hours and then in LI5 
medium for 48 hours (ie. lymphoblasts), when ftirther treated (for 48 hours) with 
either ASN 1 or ASN 2.5, were not induced to incorporate more ^HTdR than 
background cultures (ie. Con A pre-cultured cells that had been fiarther treated with 
medium rather than ASN for 48 hours). Interestingly, these background cultures 
display significantly elevated DPM, probably due to stimulation by the Con A during 
the initial pre-culture period, (Fig. 2.5, Table 2.1). In contrast, those cells that were 
pre-cultured in L I 5 only for 96 hours exhibited significant stimulation, (with indices 
of 4.7 and 6.1) when stimulated with ASN 1 or ASN 2.5 respectively. 
Control supernatants (CSNs - supernatants generated from cells cultured in 
L I 5 alone ie. no Con A) had no stimulatory effect on any of the three cell populations 
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(as expected). In fact, the ^HTdR incorporation was significantly lower than the 
background DPM in the Con A pre-cultured cells, suggesting inhibition. (See Fig. 
2.5, Table 2.1). 
When the above lymphoblast populations were left for a fijrther 5 days of pre-
culture (ie. 48 hours in Con A then 7 days in L I 5), the same ASN 2.5 was then 
stimulatory (Fig. 2.6), giving stimulation indices of 4.9 and 3.3 for cells pre-cultured 
with lug/ml and 2.5|j.g/ml respectively (Table 2.2). This was undoubtedly due to 
DPM of Con A- pre-cultured cells returning to comparable levels to splenocytes pre-
cultured in medium alone. 
Further batches of active and control supernatants were generated - one batch 
was derived from control Xenopus (termed C.CSN, C.ASN 1 and C.ASN 2.5), and 
one batch was derived from late Tx (stage 56/57) Xenopus (termed Tx.CSN, 
Tx.ASN 1 and Tx.ASN 2.5). Both batches of ASNs were able to stimulate fresh 
splenocytes (ie. tested directly ex v/'vo) from both control and early-thymectomised 
animals (Fig. 2.7). The ASN 2.5 from both control and Tx donor gave the highest 
stimulation in each case. Splenocytes from control and early-thymectomised animals 
responded with similar stimulation indices (see Table 2.3). 
2.3.2 Tumour Cytotoxicity Mediated by Xenopus Splenocytes 
2.3.2.1 Splenocytes ex vivo 
As a background from which the effect of ASNs on the ability of Xenopus 
splenocytes to lyse B^B? thymus tumour cells could be determined, several 
experiments were performed assessing the killing activity of unstimulated (ie. without 
ASN) splenocytes. Such spontaneous lysis was assessed in '^Chromium release 
assays using B3B7 tumour cell targets (a Xenopus thymus tumour cell line obtained 
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from Louis Du Pasquier and established in our laboratory - see Du Pasquier et al, 
1992). 
In these initial experiments, effector cells (control splenocytes, control 
thymocytes, and Tx splenocytes) were removed from the animal and assayed directly 
(ie. no culture period) at various E:T ratios. The results, summarised in Table 2.4, 
demonstrate that control splenocytes were unable to display significant (ie. >10% 
specific release) lysis of B3B7 tumour targets, with maximal specific ^'Cr release 
being only 6%. Thymocytes also induced no lysis of B3B7 cells, and were therefore 
usefial as controls. In comparison, splenocytes from thymectomised animals did 
exhibit significant spontaneous lysis, with percentage lysis reaching as high as 17%. 
(Neither control nor Tx splenocytes were able to lyse the human tumour cells K562 
in 6 hour ^'Cr release assays - results not shown). 
2.3.2.2 Effect of ASNs 
From this basis, experiments were performed to determine the effect of ASNs 
on specific cytotoxicity. Thus, splenocytes from both control and thymectomised 
animals were cultured at 5x10** cells/ml for 48 hours in either medium or ASN, 
before being recounted, washed, and utilised as effectors in Chromium release 
assays. Figure 2.8 illustrates the results of this experiment, and shows that in all 
cases there is a correlation between E:T ratio and percentage lysis, with more 
effector cells leading to more killing. 
The addition of ASN to the control splenocytes appears to have no effect on 
their killing ability, since the two control samples (cultured in medium or ASN) 
exhibit almost identical percentage lysis at all E:T ratios. (Highest percentage lysis 
observed was at an E:T ratio of 45:1, with medium- and ASN- treated effectors 
displaying 48% and 50% lysis respectively - Table 2.5). In comparison, the addition 
of ASN to splenocytes from a thymectomised animal had a noticeable effect, 
significantly increasing the percentage lysis observed at all E:T ratios. For example, 
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at an E:T ratio o f 45:1, Tx splenocytes cultured in medium alone exhibited only 14% 
lysis, whereas those cultured with ASN exhibited an increase to 50% lysis. 
Interestingly, the medium-cultured Tx splenocytes in this experiment exhibit killing 
levels which are comparable to those observed with Tx splenocytes tested directly 
f rom the animal (14% lysis at 45:1 for cultured Tx cells - Table 2.5- compared with 
16% lysis at 58:1 for fresh Tx cells - Table 2.4). In other words, culturing them for 
48 hours in medium does not affect their killing ability. The requirement for Tx (but 
not control) splenocytes to be cultured in ASN to become effective killers o f the 
tumour cells is interesting. The difference may be explained, in some way, by the 
lack o f T cells in Tx frogs and the consequential need to supply T cell - derived 
cytokines. 
Figure 2.9 shows the proportion o f T cells in both control and Tx splenocytes 
cultured in tumour medium for 48 hours, as determined by flow cytometry. While 
control cells contain 65% 281* cells, Tx cells contain only 22% 261* cells. 
Furthermore, the fluorescence intensity o f 2B1 staining of the Tx cells was 
significantly less than on control cells. The CDS marker monitored by F17 has gone 
from the Tx spleen. 
The induction o f anti-tumour cytotoxicity in control cells following 48 hour 
culture in medium alone was confirmed in an additional experiment. Here, control 
splenocytes were taken fresh from an animal - some were assayed directly in a 
^'chromium release assay; the rest were cultured in either medium or ASN for 48 
hours and then assayed. The results are shown in figure 2.10. As expected, the fresh 
splenocytes exhibited very little killing activity - at an E:T ratio of 40:1, the 
percentage lysis was only 2%. When the same splenocytes were then cultured with 
medium for 48 hours, the amount o f killing had increased to 22% (at 40:1). 
Although higher percentage release has been observed in previous experiments under 
similar conditions, this is still a significant increase. Incubation o f cells with ASN 
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also resulted in an increase in percentage lysis from that observed with fresh cells, but 
only to the level o f that observed with medium-cultured cells. 
2.3.3 Phenotypic and Functional Studies on Spleen Cell Populations 
Following Panning 
In the f low cytometric data presented, markers in both single and dual colour 
analyses were set up so that background staining registered at the 2% level. Dual 
fluorescence staining provides a more in depth characterisation of cell populations. 
All experiments were performed on 7 - 10 month old control animals from the 
same batch. Non-panned splenocytes were nearly always found to have 
approximately 20 - 30% B cells and 60 - 70% T cells (of which about one-third are 
C D 8 ' T cells), (Fig. 2.11) 
2.3.3.1 Panning with anti-Ig mAbs 
Initial experiments were carried out on controls, using the mAb 8E4 for 
panning which binds to surface immunoglobulin (sig) on B cells. 
Figure 2.12 illustrates the results from one o f the better separations using 
8E4, and demonstrates that panning has enriched the non-adherent population for 
2 B r cells (T cells) from 73% to 84%, while 10A9^ cells (B cells) have been depleted 
from 19%) to 3%. (Non-adherent cells have also been enriched for AM22^ [ T J cells 
from 25% to 3 1 % , as expected - results not shown). Although the adherent 
population is enriched for 10A9^ cells (64%, B cells), it is contaminated with quite a 
high proportion o f 2Br cells (17% T cells). 
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In a different panning experiment using 8E4 to achieve B cell removal, a 
•'HTdR assay was performed on all three populations (non-panned, non-adherents [T 
cell enriched], and adherents [B cell enriched] ) after stimulation with Con A and 
LPS, to determine whether cell separation affects the functionality o f the different 
lymphocytes (Fig. 2.13, Table 2.6). Non-panned splenocytes proliferated in response 
to both Con A and LPS, with a larger response to Con A (SI = 48.6) than LPS (SI = 
9.80), reflecting the higher proportion o f T cells to B cells. The non-adherents (T 
cell enriched) responded to Con A, but showed only minimal stimulation by LPS (SI 
= 1.40). The low SI o f the non-adherent cells to Con A (SI = 4.87) was in part due 
to the high background D P M of these cells. (Compare with the non-panned cells 
which have a low background DPM and thus a SI to Con A of 48.6). From the 
stimulation indices (Table 2.6), the adherent splenocytes fail to respond significantly 
to LPS. However, the actual counts for LPS are very high (40150 DPM), suggesting 
that the stimulation is masked by the very high background counts (31430 DPM) for 
the adherent cells. This may well be due to anti-IgM stimulating the B cell 
population to proliferate (See Schwager & Hadji-Azini, 1985). 
A final panning experiment was set up to examine the ability of a mix of anti-
light chain mAbs (ALC) to remove B cells. The flow cytometric results obtained 
(Fig. 2.14) were very similar to those obtained when panning with 8E4, with an 
enrichment o f T cells in the non-adherent population from 67% to 82% and a 
depletion o f B cells by half However, there were still 14% B cells in this population 
which is quite a high level of contamination. The flow cytometric data on adherent 
cells are difficult to interpret due to the poor staining of this population with either 
8E4 or ALC mAbs. It appears likely, however, that the vast majority of adherent 
cells ( Ig light chain*"") are indeed B cells with low fluorescence intensity o f 8E4 and 
A L C staining. 
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2.3.3.2 Panning for T cells 
Panning experiments were initially performed with 2B1 which is thought to 
recognise the CDS antigen on Xenopus T cells (Jurgens et al, 1995). Figure 2.15 
demonstrates that panning has enriched the non-adherent population for 8E4* cells (B 
cells) from 27% to 48%, but is unable to remove all the 281* cells (T cells), since 
there are still 20% 2B1+ cells present (about half of which are AM22'^ cells - results 
not shown). 
Adherent splenocytes were stained with 2B1/D8 (rather than 8E4/2B1) so 
that all of the 2B1 was on the F I T C channel, leaving the P E channel able to clearly 
detect any B cell contamination. This is important because 2B1 is a fairly 'sticky' 
antibody, and so if there is any left on the cells after panning, the 2° FITC-conjugated 
anti-mouse Ig Ab will bind to it and give a positive reading. Therefore, if 8E4-
+ 
FITC/2B1-PE is used, any 2B1 cells will have a double fluorescence :- red from the 
2B1-PE binding directly to the CDS, and green from the 2° FITC-conjugated Ab 
binding to the Fc region of the 2B1 used for coating the cells. (This would lead to 
'false +ve B cells'). Using 2B1-FITC/D8-PE avoids this because the only marker that 
can show on the red channel is D8-PE which binds to sig* cells. Thus, staining with 
2BI/D8 shows that the adherent cells have been enriched for 281* cells (T cells) 
from 62% to 86% and that 8 cell contamination is minimised. 
In a fijrther 281-panning experiment, non-panned or panned splenocyte 
populations were each treated with both Con A and LPS (Fig. 2.16). As expected, 
the non-panned splenocytes were able to respond well to both mitogens, with 
stimulation indices of 30.74 and 10.43 for Con A and LPS respectively (Table 2.7). 
The non-adherent cells (T cell depleted) also proliferate to both mitogens, although 
the LPS response is greater since this population is now enriched for 8 cells. (The 
Con A response is due to the contaminating T cells). Surprisingly, the adherent cells 
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(ie. the T cell-rich population) responded to Con A with an SI o f only half that o f the 
non-panned population, and were still able to show proliferation induced by LPS. 
Subsequent panning o f T cells was attempted with AM22 (or AM22 and F17 
simultaneously) to enrich for CD8* T cells. Figure 2.17 illustrates the results from a 
separation using AM22 alone, although AM22 and F17 together yielded similar 
findings. The non-panned splenocytes contain ca. 82%> T cells (which is unusually 
high), o f which just under a third (33% of all cells) are cytotoxic. The panning 
procedure was quite successful at producing a purified CD8* adherent population 
(approximately 95% pure), but it was not efficient at removing all CD8'^ cells from 
the non-adherents, since this population was contaminated with 14% CD8'^ cells. 
Also, the actual number o f recoverable adherents was very poor (only 7.4x10^ 
adherents were recovered from 1x10^ total cells). A ^HTdR uptake assay after in 
vitro treatment with Con A demonstrates that both the non-panned and non- AM22-
adherent populations are able to respond well to the Con A (Si's = 46.2 and 38.6 for 
the non-panned, and 30.5 and 28.7 for the non-adherent cells, for Con A l}ig/ml and 
Con A 2.5|ig/ml respectively). In contrast, the CD8* adherent cells showed minimal 
response (SI = 3.03 for Con A 2.5^lg/ml). (Fig. 2.18, Table 2.8). 
2.3.4 Enrichment of Cell Populations by Magnetic Bead Separation 
Antibody-coated magnetic beads (Dynal® M-450 magnetic beads) were 
employed in an attempt to improve upon the efficiency o f cell separation achieved 
using 'panning'. Resulting populations were cultured overnight (to allow adherent 
cells to detach from the beads), then dual-labelled with mAbs and analysed by flow 
cytometry to assess the success o f the separation. 
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2.3.4.1 B cell depletion / enrichment of T cells 
Attempts to remove 8 cells employed the mAb 8E4, and required several 
modifications to determine optimum conditions. Three controls were initially set up 
to ensure that the cells were not affected by incubation with the mAb or by the beads 
themselves. Figure 2.19 demonstrates that, indeed, the cells are not affected since all 
these controls have ca. 21% 8E4* cells and ca. 70% 281* cells, and thus any 
separation observed experimentally is genuine. 
To determine the optimum number o f beads required, fresh splenocytes from 
a control animal were incubated with 8E4 at a 1 in 4 dilution, and separated using 
Dynabeads® M-4S0 at bead : lymphocyte ratios of 5:1, 10:1 and 20:1. Figure 2.20 
shows both the non-adherent and adherent populations from each separation after 
overnight culture. Increasing the bead : cell ratio did not increase the extent to which 
the non-adherents were enriched for 281* cells since all three ratios resulted in an 
enrichment o f 281* cells from 65% in the non-beaded population to 81/82%) in the 
non-adherents. However, there were differences in the percentage contamination 
with 8 cells : ratios o f 10:1 and 20:1 were both able to deplete the non-adherents of 
8 cells from 19%o to 3%i, but a ratio o f 5:1 was only able to deplete to 5%. The 
adherent population (which should have been pure 8E4* cells) were odd in all three 
cases with a significant contamination of 281* cells (ca. 27%) and maximally only 
37%) 8E4* cells were recorded. These latter percentages are probably misleading due 
to the low level o f sIgM on B cells that may have been activated overnight by the 
anti-IgM attached to the beads. 
During these initial experiments, it was observed that the number o f 
recoverable adherent cells was very poor, and it was hypothesised that this was 
because many of the splenocytes were still bound to the Dynabeads® even after 
overnight culture, and were hence being removed with the beads when placed in the 
Magnetic Particle Concentrator. Consequently, an 8E4-separation was set up to 
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investigate the effects o f a longer culture period following Dynabead® separation. 
The separation was performed in duplicate so that one batch o f adherent cells could 
be cultured over one night (17 hours), and the other batch could be cultured over two 
nights (41 hours). As Figure 2.21 demonstrates, the longer culture period actually 
produces worse results since the adherent population contains only a very low 
percentage o f 8E4'^  cells (ca. 16%)), and those that were present showed a high 
incidence o f dead cells (data not shown). In comparison, the separation with only 
one night culture enriched the non-adherent population for 2B1* cells from 75% to 
87%) (with only 8%) 8E4* contamination). Furthermore, the adherent cells contained 
a distinctly elevated (47%) population of 8E4* cells (albeit a dull population), 
although was still contaminated with a significant percentage o f 2B1* cells (17%). 
In an attempt to reduce this 2 B r contamination o f the adherent population 
(which may be 2Bl'^ cells trapped by the adherent cells moving to the side), a post-
separation wash was added. Thus, after removal of the initial non-adherent cells, the 
eppendorf was removed from the MPC and the adherents thoroughly resuspended in 
Iml APBS/FCS. These re-washed splenocytes were then returned to the MPC and 
the non-adherent supernatant added to the 'non-adherent' sample. As Figure 2.22 
demonstrates, this extra wash had great effect, with virtually no 2B1* contaminants 
(2% in the 'washed' sample compared with 18% contamination in the 'unwashed' 
adherent sample). This was a significant improvement (which was thus employed in 
all further experiments), and demonstrated that the technique was successful in 
binding only to 8E4* cells. The percentage o f 8E4'^  cells in the 'washed' adherent 
population was still recorded as only 4.5% by positive analysis, but the shift in the 
F L l brightness peak indicates that perhaps all these cells are slgiyT'"". 
The final experiment employed 8E4 at 1 in 4 (better separation than using 
8E4 at 1 in 8 - results not shown), utilised extra washing o f the initial adherent cells, 
and examined cells by flow cytometry after overnight culture. The only variation 
used here was to determine i f the initial volume of 8E4 used to coat IgM* cells was o f 
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any importance. Thus, fresh splenocytes (1x10*) were incubated in either 1ml or 
0.5ml o f 8E4 (1 in 4) before being rotated with the beads. As Figure 2.23 
demonstrates, both 1ml and 0.5ml o f 8E4 produced extremely similar results, 
reducing the number o f 8E4* cells from 29% in the non-beaded population to 7% and 
6% in the non-adherent population for 1ml and 0.5ml respectively. Similarly, 281* 
cells were enriched from 63% in the non-beaded population to 80% and S\% in the 
non-adherent populations. The adherent populations in each separation were also 
very similar; both consisting o f dull 8E4* cells and only 3% CD5* T cell 
contamination. The mAb incubation volume was thus kept at 0.5ml for all fijrther 
experiments. Furthermore, the conditions used in this experiment produced the 
cleanest enrichment utilising the 8E4 mAb, and were thus utilised in subsequent 
experiments. 
2.3.4.2 T cell depletion / enrichment of B cells 
Following the optimum conditions determined for removing adherent 8 cells 
and enriching for T cells (ie. incubation in 0.5ml, 10:1 beads, overnight culture, 
washing o f adherents), T-cell removal was attempted using the mAb 281 (which 
binds to the Xenopus CD5 antigen). 
Two 2B1 concentrations were used : 1 in 5 and 1 in 10, and the results are 
shown in Figure 2.24. The technique was successful, reducing the number o f 281* 
cells from 62% in the non-beaded population to only 5%) and 6% (for 1 in 5 and 1 in 
10 respectively) in the non-adherent cell populations. Concurrently, 8E4* cells are 
enriched from 29% in non-beaded splenocytes to 6\% and 64% (for 1 in 5 and 1 in 
10 respectively) in the non-adherent populations. Although the percentages o f 281* 
cells in the adherent populations are recorded by the flow cytometer as fairly low 
(36%) and 59% for 1 in 5 and 1 in 10 respectively), these values may be misleading 
because the 2B1"'" staining is dull. Also, the 281* adherents are duller following 
initial incubation with the more concentrated mAb (ie. 1 in 5 : mean fluorescence = 
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1.56, compared with 1.93 at 1 in 10 - results not shown), suggesting that the 2B1 
used for coating the cells is down-regulating CD5 expression. (Consequently, flirther 
experiments were set up using 2B1 at 1 in 15 and 1 in 20. Although the resulting 
2B1* adherents were brighter, the separation was not as clean and therefore the 
populations not as usefiji - results not shown). Cells found in quadrant 3, where the 
PE-fluorescence intensity has somewhat increased compared with control Ab-stained 
cells, may actually be CDS" '^"" T cells. The adherents are probably, therefore, 
predominantly CD5* T cells, as the cells present are a single, discreet population, and 
there is only a negligible contamination with 8E4* B cells (Wo in the 1 in 10 sample). 
Separations were also attempted using AM22 ( a |J, isotype antibody) to try 
and remove CD8* cells. Figure 2.25 shows the results of the separation using AM22 
at 1 in 125. Unfortunately there were not enough adherent cells to analyse. Non-
beaded splenocytes (Figure 2.25a) contained ca. 60% 2 B r cells, o f which just over a 
third were F17* cells ( 24% of the total lymphocyte population). Beading depletes 
the non-adherent population o f 2 B r cells to 46% and AM22' ' cells to 10%, ie. 
removing about half o f the CD8'^ population. The CT3Ag stain o f the beaded 
population shows a 9% CT3-FITC'^ population - this is likely to represent AM22 -
coated cells still in this population. 
2.3.5 Assessment of the Killing Activity of Cell Populations 
Enriched by Beading. 
In an attempt to identify the particular cell population responsible for 
spontaneous cytotoxicity, splenocytes from a control Xenopiis were subjected to 
magnetic bead separation using either 2B1 (at 1 in 10) or 8E4 (at 1 in 4), and the 
resulting populations used as effectors in ^'Chromium release assays. (Unfortunately, 
there were usually insufficient numbers o f adherent cells available for their killing 
ability to be assayed). All other conditions for separation were those determined as 
optimum in this study (see sections 2.3.4.1 and 2.3.4.2). The animal had been 
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injected three days previously with 1x10*^  B387 tumour cells, via the dorsal lymph 
sac, in order to boost the level o f cells exhibiting natural killer activity. 
Figure 2.26 illustrates the flow cytometric data from these separations, and 
demonstrates that both separations have been successfijl in enriching each population 
for the appropriate cell type. (Beading with 281 depletes the non-adherent 
population o f 2B1* cells from 16% [in the non-beaded population] to 24%), while 
enriching the adherent population to 93% 281* cells. Beading with 8E4 depletes the 
non-adherent population o f sig* cells from 2\% [in the non-beaded population] to 
6%), while enriching the adherent population to 86''/o D8* cells). Figure 2.27 
illustrates the killing activity towards BjB? cells observed in each of these populations 
and compares them with the killing observed in a corresponding 'unseparated' 
splenocyte sample. The most noticeable difference in killing activity is that displayed 
by the '281-adherents' which are almost pure 281* cells (93%)). These cells exhibit 
the lowest amount o f killing out o f all the populations, reaching only 15% lysis at an 
E:T ratio o f 13:1. (At a similar E:T ratio, the other populations are displaying 
between 40% and 50% lysis). These 281* (adherent) cells are viable since they can 
respond well (by ^HTdR uptake) to Con A (data from lab, unpublished). 
The other populations - 'unseparated', '281-non-adherents' and '8E4-non-
adherents' - show very similar killing patterns, although there are slight differences in 
the actual percentage lysis observed. Generally, for each E:T ratio, the greatest 
killing is seen in the '8E4-non-adherents' (T cell enriched), followed by the '281-non-
adherents' (8 cell enriched), and then least is seen in the unseparated population. For 
example, at an E:T ratio o f 10:1, percentage lysis is 47%), 43% and 38%) for '8E4-
non-ads', '281 -non-ads', and 'unseparated' respectively. 
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Figure 2.3 : Assessment o f optimal Con A dose for Xenopus splenocyte 
stimulation in L I 5 culture medium 
Splenocytes prepared directly ex vivo from a 6 month old control Xenopiis laevis 
were dispensed into each well o f a 96-well, flat-bottomed plate in 100(4,1 aliquots ( I x 
10*^  lymphocytes/ml) in \ % FCS-supplemented L I 5 medium. Cultures were set up 
in triplicate, each well was pulsed with \\xC\ ^HTdR at 48 hours and harvested at 66 
hours. Con A dilutions refer to 'in-well' concentrations. DPM = degenerations per 
minute ' ' H thymidine. 
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Figure 2.4 : HTdR uptake o f control and both early (day 7) - and late (day 35) -
thymectomised (Tx) Xenopiis when stimulated with Con A at l^g/ml . All animals 
were 23 months old. (Some cells were set up with Con A + O.IM a-mm to test the 
ability o f a-mm to abrogate Con A stimulation). 
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Figure 2.5 : ^HTdR uptake o f control Xenopus splenocytes (pre-cultured with 
either L I 5 for 96 hours or Con A [either l | ig/ml or 2.5ng/ml] for 48 hours then L I 5 
for 48 hours) when treated for 48 hours with either CSN, ASN 1 or ASN 2.5. 
Xenopus were 23 months old. 
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Table 2.1 : Stimulation indices produced by 48 hour CSN- and ASN- treatment of 
control Xenopus splenocytes (that had been precultured with either L I 5 for 96 hours 
or Con A [either l | ig /ml or 2.5|ig/ml] for 48 hours then L I 5 for 48 hours). Xenopus 
were 23 months old. 
96 hour preculture Stimulation indices when splenocytes treated for 48 hours with: 
CSN ASN 1 ASN 2.5 
L I 5 medium 0.77 4.72 6.07 
Con A 1 |4g/ml 0.47 0.97 1.04 
Con A2.5|ag/ml 0.32 0.98 0.96 
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Figure 2,6 : '^HTdR uptake o f control Xenopus splenocytes (pre-cultured with 
either L15 for 9 days or with either l | ig/ml or 2.5(j,g/ml Con A for 48 hours then L15 
for 7 days) when treated for a fijrther 48 hours with either CSN or ASN 2.5. 
Xenopus were 26 months old. 
2500 
2000 + 
1500 4-
D P M 
1000 + 
500 + 
• medium 
• CSN 
• ASN 2.5 
1111 
L I 5 Con A Con A 
medium lug/ml 2.5ug/ml 
9 day preculture 
Table 2.2 : Stimulation indices produced by CSN- and ASN- treatment for 48 
hours o f control Xenopus splenocytes (pre-cultured with either L I 5 for 9 days or 
Con A for 48 hours then L I 5 for 7 days). Xenopus were 26 months old. 
9 day preculture Stimulation indices when splenocytes treated with: 
CSN ASN 2.5 
L I 5 medium - -
Con A 1 fJg/ml 0.81 4.86 
Con A 2.5|ig/ml 0.96 3.25 
57 
Figure 2 .7 : ^HTdR uptake o f control and early-thymectomised Xenopus 
splenocytes when treated for 48 hours with various CSNs and ASNs produced from 
either control (C) or late (stage 56/7) - thymectomised (Tx) animals. Xenopus were 
6 months old. 
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Table 2.3 : Stimulation indices produced by CSN- and ASN- treatment of control 
and early-thymectomised (Tx) Xenopus splenocytes. Xenopus were six months old. 
Source o f Responder 
Splenocytes 
Stimulation indices when splenocytes treated with: 
C.CSN C.ASN 1 C.ASN 2.5 
Control 
Early Tx 
0.76 
0.81 
2.94 
3.84 
4.33 
4.88 
Source o f Responder 
Splenocytes 
Stimulation indices when splenocytes treated with: 
Tx. CSN Tx. ASN 1 Tx. ASN 2.5 
Control 
Early Tx 
0.54 
0.89 
2.70 
1.64 
5.26 
6.01 
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Table 2.4 : Percentage ^'Cr release from B3B7 tumour target cells exhibited by 
control splenocytes, control thymocytes, and Tx splenocytes in a 6 hour assay. 
Xenopus were 11 months old. 
Effector cells were assayed fresh from the animal, at effector : target ratios of 29:1 
100:1 
Effector cell E:T ratio % lysis 
Control splenocytes 50 1 -2 
100 1 6 
Control thymocytes 50 1 -3 
100 1 -7 
Tx splenocytes 29 1 17 
58 1 16 
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Figure 2.8 : Percentage ^'chromium release from B3B7 tumour target cells induced 
by control and Tx splenocytes after their treatment with either medium or ASN. 
Both Xenopus were 20 months old. 
Splenocytes were cultured at 5x10^ for 48 hours in either B3B7 tumour medium or 
ASN, then washed and recounted, and used as effectors at E:T ratios of 3:1 ^ 4 5 : 1 . 
- •—Contro l+ 
med 
-h.— Control + 
ASN 
- 0 — T x + med 
- A — T x + ASN 
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% lysis 40 + 
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3:1 5:1 11:1 22:1 
E : T ratio 
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Table 2.5: Percentage ^'chromium release from B3B7 tumour target cells 
exhibited (in a 6 hour assay) by control and Tx splenocytes after treatment with either 
medium or ASN. Both Xenopiis were 20 months old. 
Splenocytes were cultured at 5x10*^  for 48 hours in either B3B7 tumour medium, with 
or without ASN, then washed and recounted, and used as effectors at E:T ratios of 
3:1 ^ 4 5 : 1 . 
Effector Cells Percentage lysis at the Allowing E: T ratios : 
(Splenocytes) 3:1 5:1 11:1 22:1 45:1 
Control + Medium 4 10 26 37 48 
Control + ASN 4 9 22 36 50 
Tx + Medium 4 6 5 12 14 
Tx + ASN 15 26 32 44 50 
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Figure 2.9 : Flow cytometric analysis of splenocytes from both a control and a 
thymectomised Xenopus laevis after 48 hour culture in B3B7 tumour medium. Both 
Xenopus were 20 months old. 
Cells were dual labelled for flow cytometry with the pan T cell mAb 2BI (1:80) and 
the anti-CD8 mAb Fl7 (1:200). 
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Figure 2.10 : Percentage ^'Chromium release from B3B7 tumour target cells induced 
by either fresh control splenocytes or those cultured in medium or ASN. The 
Xenopus was 13 months old. 
Splenocytes were cultured at 5x10* for 48 hours in either B3B7 tumour medium or 
ASN, then washed and recounted, and used as effectors at E:T ratios of 3:1 —> 40:1. 
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Figure 2.11 : Flow cytometric analysis of splenocytes from an 8 month old control 
Xenopus laevis. 
Cells were dual labelled for flow cytometry with the mAbs 8E4 (1:60) [anti-lgM] 
and 281 (1:80) [anti-CD5], or AM22 (1:400) [anti-CD8] and 231 (1:80). 
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Figure 2.12: Flow cytometric analysis of the non-panned, non-adherent and 
adherent splenocytes from a 7 month old control Xenopus Ipevis, panned with 8E4. 
Panning was performed with 8E4 (anti-IgM) at a 1 in 60 dilution. Cells were dual 
labelled for flow cytometry with the mAbs 10A9 (1:60) [anti-IgM] and 2B1 (1:80) 
[anti-CD5]. 
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Figure 2.13 : ^HTdR uptake (DPM) of the non-panned, non-adherent and adherent 
splenocytes from a 10 month old control Xenopiis laevis (panned with 8E4), when 
treated with Con A or LPS. 
Panning was performed with 8E4 at a 1 in 60 dilution. Con A was used at 2.5|ag/ml, 
and LPS was used at 0.5mg/ml. 
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Table 2.6 : Stimulation indices produced by Con A and LPS treatment of the non-
panned, non-adherent and adherent splenocytes from a 10 month old control Xenopus 
laevis panned with 8E4. 
Panning was performed with 8E4 at a 1 in 60 dilution. Con A was used at 2.5ng/ml, 
and LPS was used at 0.5mg/ml. 
Splenocyte population Stimulation indices when splenocytes treated with: 
Con A LPS 
non-panned 48.6 9.80 
non-adherent 4.87 1.40 
adherent 0.11 1.28 
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Figure 2.14: Flow cytometric analysis of the non-panned, non-adherent and 
adherent splenocytes from an 8 month old control Xenopus laevis panned with anti-
light chain mAbs (ALC mix). 
Panning was performed with ALC mix at 1 in 50 dilution. Cells were dual labelled 
for flow cytometry with the mAbs a) 8E4 (1.60) [anti-lgM] and 2B1 (1:100) [anti-
CD5] or b) ALC (1:50) [anti-slg] and 281 (1:100). 
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Figure 2,15: Flow cytometric analysis of the non-panned, non-adherent and 
adherent splenocytes from an 8 month old control Xenopus^ laevis, panned with 281. 
Panning was performed with 281 SN at 1 in 5 dilution. Cells were dual labelled for 
flow cytometry with the mAbs 8E4 (1:60) [anti-lgM] and 281 (1:80) [anti-CD5], or 
281(1:200) and D8 (1:300) [anti-lgM]. 
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Figure 2.16: "^ HTdR uptake of the non-panned, non-adherent and adherent 
splenocytes from a 10 month old control Xenopus laevis (panned with 2B1), when 
treated with Con A or LPS. 
Panning was performed with 2B1 at a 1 in 5 dilution. Con A was used at 2.5|ig/ml, 
and LPS was used at 0.5mg/ml. 
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Table 2.7 : Stimulation indices produced by Con A- and LPS- treatment of the 
non-panned, non-adherent and adherent splenocytes from a 10 month old control 
Xenopus laevis, panned with 2B1. 
Panning was performed with 2B1 at a 1 in 5 dilution. Con A was used at 2.5|j,g/ml, 
and LPS was used at 0.5mg/ml. 
Splenocyte population Stimulation indices when splenocytes treated with: 
Con A LPS 
non-panned 30.74 10.43 
non-adherent 6.13 7.36 
adherent 16.15 13.52 
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Figure 2.17: Flow cytometric analysis of the non-panned, non-adherent and 
adherent splenocytes from an 8 month old control Xenopus laevis, panned with 
AM22. 
Panning was performed with AM22 at a 1 in 400 dilution. Cells were dual-labelled 
for flow cytometry with the mAbs AM22 (1:400) [anti-CD8] and 2B1 (1:80) [anti-
CD5]. 
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Figure 2.18: ''HTdR uptake of the non-panned, non-adherent and adherent 
splenocytes from an 8 month old control Xenopus laevis (panned with AM22), when 
treated with Con A for 48 hours. 
Panning was performed with AM22 at a 1 in 400 dilution. Con A was used at both 
l|ig/ml and 2.5|ig/ml. 
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Table 2.8 : Stimulation indices produced by Con A treatment of the non-panned, 
non-adherent and adherent splenocytes from an 8 month old control Xenopus laevis, 
panned with AM22. 
Panning was performed with AM22 at a 1 in 400 dilution. Con A was used at both 
l|ig/ml and 2.5|ig/ml. 
Splenocyte population Stimulation indices when splenocytes treated with: 
Con A 1 Con A 2.5 
non-panned 46.2 38.6 
non-adherent 30.5 28.7 
adherent - 3.03 
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Figure 2.19 : Flow cytometric analysis of the non-adherent splenocytes from three 
different control Dynabead® separations. 
Freshly prepared splenocytes from a 15 month old control Xenopus laevis were 
incubated in either APBS/FCS or 8E4 (diluted at 1 in 4 in APBS/FCS). After 45 
minutes one set of control cells (no 8E4) were mixed with Dynabeads® M-450 at 
10:1 beads:cells, the other two cell samples were rotated without beads. After 
overnight culture (to achieve detachment of adherent cells from beads), non-
adherents from each sample were dual-labelled for flow cytometry with the mAbs 
8E4 (1:60) [anti-lgM] and 2B1 (1 :80) [anti-CD5]. 
(Figure 2.19 is shown on the following page). 
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Figure 2.20 : Flow cytometric analysis of the non-adherent and adherent 
splenocytes from Dynabead® separation using 8E4 at bead : lymphocyte ratios of 5:1, 
10:1 and 20:1. 
Freshly prepared splenocytes from a 15 month old control Xenopus laevis were 
subjected to Dynabead® separations under the following conditions: 
a) no 1° Ab, no beads 
b) cells incubated with 8E4 (1 in 4), beads : lymphocytes 5:1 
c) cells incubated with 8E4 (1 in 4), beads : lymphocytes 10:1 
d) cells incubated with 8E4 (1 in 4), beads : lymphocytes 20:1 
After overnight culture, all populations were dual-labelled for flow cytometry with 
the mAbs 8E4 (1:60) [anti-IgM] and 2B1 (1:80) [anti-CD5]. 
(Figure 2.20 shown on the following two pages) 
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Figure 2.21: Flow cytometric analysis of the non-beaded, non-adherent and 
adherent splenocytes from a Dynabead® separation using 8E4, after 17 or 41 hours 
culture in vitro. 
All splenocytes were from a 15 month old control Xenopus laevis. Experimental 
cells were incubated in 8E4 (1 in 4), and mixed with beads : cells 10:1. Separations 
were performed in duplicate and cultured for either: 
a) 17 hours or 
b) 41 hours, 
before being analysed by flow cytometry. All populations were dual-labelled with the 
mAbs 8E4 (1:60) [anti-IgM] and 2B1 (1:80) [anti-CD5]. 
(Figure 2.21 is shown on the following page) 
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Figure 2.22 : Flow cytometric analysis of the non-beaded and either 'washed' or 
'unwashed' adherent splenocytes from a Dynabead® separation using 8E4. 
Freshly prepared splenocytes from a 15 month old control Xenopus laevis were 
treated with 8E4 at a 1 in 4 dilution. Duplicate separations were set up (Beads : cells 
10:1), and the resulting adherent populations either removed directly in the MPC 
(unwashed) or removed, washed with 1ml APBS/FCS and then removed again in the 
MPC (washed). All populations were cultured overnight then dual-labelled for flow 
cytometry with the mAbs 8E4 (1:60) [anti-IgM] and 2B1 (1:80) [anti-CD5]. 
(Figure 2.22 is shown on the following page). 
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Figure 2.23 : Flow cytometric analysis of overnight-cultured non-beaded, non-
adherent and adherent splenocytes from Dynabead® separations utilising different 
initial mAb incubation volumes. 
All splenocytes were from a 15 month old control Xenopus laevis. Experimental 
cells were incubated in either 
a) 1ml or 
b) 0.5ml 
of 8E4 (1 in 4), then mixed with beads at 10:1 beads : cells. Washing of cells during 
magnetic bead separation was carried out. All populations were dual-labelled for 
flow cytometry with the mAbs 8E4 (1:60) [anti-IgM] and 2B1 (1:80) [anti-CD5]. 
(Figure 2.23 is shown on the following page) 
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Figure 2.24: Flow cytometric analysis of the non-beaded, non-adherent and 
adherent splenocytes from a Dynabead® separation using 2B], assessing two 2B1 
concentrations, under optimal conditions described in 2.3.4.1. 
All splenocytes were from a 15 month old control Xenopus laevis. Experimental 
cells were incubated in 2B1 at either 
a) 1 in 5 or 
b) 1 in 10, 
then mixed with beads at 10:1 beads : cells. All populations were cultured overnight 
and then dual-labelled for flow cytometry with the mAbs 8E4 (1:60) [anti-IgM] and 
2B1 (1:80) [anti-CD5]. 
(Figure 2.24 is shown on the following page) 
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Figure 2.25 : Flow cytometric analysis of the non-adherent splenocytes from a 
Dynabead® separation using AM22. 
Freshly prepared splenocytes from a 16 month old control Xenopus laevis were 
subjected to Dynabead® separation: 
a) no 1° Ab, no beads 
b) cells incubated with AM22 (1 in 125), beads: cells 10:1 
After overnight culture, populations were dual-labelled for flow cytometry with the 
mAbs CT3 (1:20) [anti-chicken CD3] and Ig (1:40) [mouse I g d ] , or 2B1 (1:15) 
[anti-CD5] and F17 (1:200) [anti-CD8]. 
(Figure 2.25 is shown on the following page) 
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Figure 2.26: Flow cytometric analysis of the splenocyte populations (from 
Dynabead® separations using either 8E4 or 2B1) tested for their killing ability in a 
separate ^'Cr-release assay. 
Freshly prepared splenocytes from a 17 month old control Xenopus laevis were 
incubated with either 
a) 2B1 (1 in 10) or 
b) 8E4 (1 in 4), 
then mixed with beads at 10:1 beads : cells. After separation and overnight culture, 
an aliquot of each population was removed and dual-labelled for flow cytometry with 
the mAbs 2B1 (1:15) [anti-CD5] and D8 (1:100) [anti-IgM]. (Non-beaded cells 
were labelled with either 2B1 (1:80) and F17 (1:200) [anti-CD8], or 8E4 (1:60) 
[anti-IgM] and D12.2 (1:200)). 
(Figure 2.26 is shown on the following page) 
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Figure 2.27 : Percentage lysis of ^'Chromium-labelled B 3 B 7 tumour target cells 
exhibited by the splenocyte populations from Dynabead® separations using either 8E4 
or 281, Unseparated splenocytes were also assayed. 
Freshly prepared splenocytes from a 17 month old control Xenopus laevis were 
incubated with either 
a) 2B1 (1 in 10) or 
b) 8E4 (1 in 4), 
then mixed with anti-Ig magnetic beads at 10:1 beads : cells. After separation and 
overnight culture, the cells were washed and recounted, then used as effectors in 
^'Chromium-release assays at E:T ratios of 1.5:1 20:1. FACS traces shown in 
previous figure. 
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2.4 Discussion 
2.4.1 Generation of Active Supernatants by Con A Stimulation of 
Splenocytes. 
The T-cell mitogen Concanavalin A was used in a series of in vitro 
stimulation experiments to probe optimal conditions for generating active 
supernatants (ASNs) from Xenopus splenocytes. The extent to which the splenocytes 
were stimulated by Con A was assessed in tritiated thymidine (^HTdR) assays, where 
stimulated cells display high "^ HTdR incorporation (due to their active proliferation) 
compared to medium-cultured cells. In this preliminary study. Con A concentrations 
of both l^ig/ml and 2.5|ig/ml were capable of stimulating splenocytes. Athough the 
range of stimulation indices varied from animal to animal, the optimum Con A 
concentration was always found to be 2.5|ag/ml, which is in agreement with Ho 
(1992), and therefore this concentration was used throughout the subsequent 
experiments. Since Con A is a T cell mitogen, it would be expected that there would 
be no response to this mitogen in early-thymectomised Xenopus, as these should have 
no T cells (see Gravenor et al, 1995). This proved to be the case, since no 
stimulation was observed in the early- (stage 48, days 7 old) thymectomised animals. 
In contrast, there was clearly some stimulation in the late- (stage 56/57, 35 days old) 
thymectomised frogs, presumably due to T cells that had escaped to the periphery 
before late thymectomy was performed. 
These preliminary experiments pointed to the likelihood that Con A would be 
capable of generating active culture supernatants from Xenopus T cells, for use in 
promoting NK-like cell activity. Further studies revealed that the sugar a-
methylmannoside (at O.IM) was effective at removing all the Con A activity (in 
agreement with Ho, 1992). Consequently, any stimulation seen in later assays of 
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these ASNs is likely to be assigned to secreted cytokine, rather than residual Con A 
in the culture. ASNs were then tested for their stimulatory capabilities against 
different lymphocyte populations. 
Initial experiments were carried out on pre-cultured cells. Splenic 
lymphoblasts (ie. cells that had already been pre-cultured for 48 hours with Con A) 
were not induced to incorporate more '^ HTdR than cultures lacking ASN. 
Presumably such cells, which were already stimulated by the Con A during the pre-
culture period, are unresponsive to further stimulation, possibly due to their own 
lymphokine production. However, when these Con A-derived lymphoblasts were left 
for a fijrther 5 days in LI5 culture medium, they became susceptible to addition of 
growth factors in the ASN. This phenomenon could relate to their own cytokine 
production now being insufficient at this longer time point after Con A stimulation. 
Further batches of Con A-derived ASNs were generated from both control 
and late-thymectomised animals. Both were tested against fresh splenocytes (ie. ex 
vivo), rather than pre-cultured cells, and were able to stimulate ^HTdR incorporation 
in such targets. ASNs from the control were able to stimulate fresh splenocytes from 
both control and early-thymectomised animals. This is in agreement with Turner et. 
al. (1991) who demonstrated that cells from early-thymectomised Xempiis 
(especially the non-Ig^ cell population) could proliferate well in response to both 
PHA- (phytohaemagglutinin) and MLC-(mixed leukocyte culture) induced 
supernatants. Since early-thymectomised animals should contain no T cells, this 
suggests that there are non-T / non-B [NK-like ?] cells present in these animals that 
are able to proliferate to cytokines (such as T cell growth factors [IL-2-like] that are 
found in ASNs of T mitogen-stimulated cells. (Watkins & Cohen, 1987; Haynes & 
Cohen, 1993). Interestingly, the early-Tx cells exhibit a slightly better proliferative 
response than the control cells, which could conceivably be due to either a high 
proportion of TCGF-reactive cells, or to an enhanced responsiveness of individual 
splenocytes in Tx frogs to respond to the ASNs. 
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In conclusion, it was likely that the Con A-derived ASNs generated in this 
study contained cytokines, particularly IL-2 or IL-2-like factors. Such ASNs are 
therefore potentially usefial in promoting activation of natural killers (which are 
known to constitutively express IL-2 receptors, Kos & Engelman, 1996). The ability 
of such ASNs to potentiate spontaneous cytotoxicity of Xenopus lymphocytes 
towards tumour target cells was then addressed. 
2.4.2 Tumour Cytotoxicity Mediated by Xenopus Splenocytes : 
Effects of ASN Treatment 
Before the effects of the ASNs on the ability of splenocytes to lyse tumour 
targets could be determined, it was first necessary to assess the level of spontaneous 
cytotoxicity effected by Xenopus lymphocytes without added cytokine. 
Consequently, several experiments were performed assessing the ability of Xenopus 
splenocytes to lyse ^'Cr-labelled B3B7 tumour cell targets (a Xenopus thymus tumour 
cell line obtained from Louis Du Pasquier and established in our laboratory - see Du 
Pasquier et a/, 1992; Robert et al, 1994). These B3B7 cells fail to express MHC I and 
I I proteins and, given that the presence of MHC proteins on target cells renders them 
resistant to NK cell cytolytic activity (Karre et al, 1986; Ljunggren and Karre, 1990; 
Storkus et al, 1989), are therefore good candidates as NK targets. 
Fresh, untreated splenocytes from control animals exhibited only minimal 
spontaneous lysis of tumour targets, whereas those from early-thymectomised 
animals exhibited significant spontaneous cytotoxicity. These results are interesting 
since they suggest that the lymphocytes in thymectomised animals exhibit more 
'natural-killer-like' cell activity than do those from control animals. This implies that 
Xenopus NK-like cells develop extrathymically. Furthermore, i f natural killer cells 
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represent a primitive form of immune defence, active before T cells are fully 
developed (Janeway, 1989), then it might be expected that they play a greater role in 
a thymectomised animal (who has no T cells) than in a control (whose defence 
strategy is dominated by T cells). Natural killer cells may, therefore, be the means by 
which thymectomised animals can survive. 
Several investigations have researched the effect of interleukin-2 on 
mammalian lymphocytes, in particular on natural killer cells. For example, Trinchieri, 
et al (1984) found that recombinant interleukin-2 (purified to homogeneity) induced a 
rapid and potent enhancement of the spontaneous cytotoxicity displayed by human 
peripheral lymphocytes. Furthermore, when the cells mediating the cj^iotoxicity were 
examined, they were found to have surface markers characteristic of natural killer 
cells, and were generated from the same lymphocyte subset that mediated NK 
activity. To the best of our knowledge, such cytokine activation of natural killer cell 
activity has not previously been investigated in Xenopus. Several experiments were 
performed here whereby splenocytes from both control and thymectomised animals 
were cultured with putative cytokine-rich Con A-derived ASNs, and then assessed 
for their cytolytic activity (against B3B7 tumour cells). 
When control splenocytes were cultured for 48 hours with medium alone, 
cytotoxicity towards tumour cells was now readily apparent, suggesting that there is 
some factor in the medium which is stimulating the cells into becoming active killers. 
Quite possibly this phenomenon is actually due to a component of the medium 
stimulating the T cells present in the control animal - these stimulated T cells then 
produce cytokines, and it is these cytokines which could then promote NK-like cell 
activity. Consequently, any further addition of cytokines, i.e. from the ASN, has no 
eflFect because the cells are already highly stimulated. 
When splenocytes from a thymectomised Xenopus were cultured with 
medium alone, the level of anti-tumour lysis was approximately the same as that 
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observed in Tx splenocytes assayed directly ex vivo, indicating that for these (T-
deficient) lymphocytes, 48 hour culture in medium has no effect. However, when 
these Tx lymphocytes were cultured for 48 hours in ASN, there was a significant 
increase in cytolytic activity. The fact that Tx splenocytes cultured in ASN became 
especially effective killers of the tumour cells is interesting. This finding is indicative 
of lymphokine-activated killing in Xenopus, and lends support to the concept that the 
tumour cell lysis is mediated by NK-like cells. 
2.4.3 Enrichment / Depletion of Spleen Cell Populations By 
'Panning'. 
One of the goals of this study was to enrich Xenopus splenocyte populations 
for natural killer cells, in order to obtain significant numbers of such purified cells for 
raising anti-NK cell antibodies, and for probing NK cell functioning. This was 
initially attempted through 'panning' with appropriate monoclonal antibodies. 
Removal of B cells : 
At the outset of these experiments, it was considered that if B cells could be 
removed from the spleen, this would offer an excellent way to eventually probe NK-
like cells in Tx animals, which are already devoid of T cells. However, in order to 
avoid wasting valuable Tx frogs, initial experiments were, in fact, carried out on 
control animals, using the mAb 8E4 which binds to surface immunoglobulin (slg) on 
B cells (Langeberg et al, 1987). Removal of B cells by panning was reasonably 
successfijl, although the purity of the panned populations was sometimes a little 
disappointing. "^ HTdR assays of each of the three populations (non-panned, non-
adherents and adherents), following stimulation with either Con A or LPS, confirmed 
that the separated lymphocyte subsets are still functional after panning. However, the 
very high counts for the adherent cells treated with medium alone (ie. no mitogen). 
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suggests that the panning procedure itself causes massive stimulation of the cells, 
which is likely to be a disadvantage of the technique. (It has been shown, in fact, that 
lymphocytes may be stimulated by treatment with anti-Ig - Schwager & Hadji-Azini, 
1985. This is due to cross-linking of the receptors such that the cell thinks that it has 
contacted antigen). 
In order to improve B cell removal through panning, an experiment was set 
up to examine the ability of a mix of anti-light chain mAbs (ALC - Hsu, Lefkovits et 
al, 1991) to remove B cells. Unfortunately, the mAb mix was not as successful as 
8E4, since it failed to remove a significant proportion of B cells from the non-
adherent population. 
Removal of T Cells : 
Panning experiments were also performed with the mAb 2B1 (against the 
CD5 antigen - Jurgens et al, 1995), as a means of depleting a cell population of T 
cells, since if this were successfijl, it might represent a useflil means of obtaining a 
'non-T' population without using up precious thymectomised animals. Panning with 
2B1 was reasonably successful at producing a 'pure' adherent population of T cells. 
Unfortunately, it was not so successfial at producing a fully T-cell-depleted non-
adherent population since there were still 20% 2Br cells present. (One of the 
inherent problems with panning for T cells in control animals is that the large 
percentage of T cells present makes it extremely difficult to remove them all. 
Potentially, T-cell-panning would be a better technique for removing any residual T 
cells remaining in a thymectomised animal, to ensure a total lack of T cells). ^HTdR 
assays showed that all populations were functional after panning. 
Panning experiments were also performed with AM22 (or AM22 - Flajnik et 
al, 1990 - and F17 - Ibrahim et al, 1991 - simultaneously) in an attempt to deplete the 
splenocyte population of CD8"' T cells. I f these could be successflilly removed, any 
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cytolytic activity observed in the remaining population could be assigned to a 
lymphoid subset other than the CDS*, putative cytotoxic cell subset (Flajnik et 
al, 1990). The procedure was quite successful at producing a purified CD8* adherent 
population, but was inefficient at depleting all CD8"^  cells from the non-adherents 
since there was still a high level of CD8* contamination in this population. A ^HTdR 
assay following in vitro treatment with Con A demonstrated that both the non-
panned and non-adherent populations were able to respond well, and are therefore 
still fijnctional after panning, but the CD8^ adherents were not. This is extremely 
interesting, since it is known that in mammals, the main producers of IL-2 are CD4^ 
helper T cells (Roitt et al, 1989), with only a small amount being produced by CDS'" 
cells. Therefore, it is possible that the lack of stimulation in the adherent (CD8"^ ) 
population is because these cells do not normally produce IL-2, and are therefore 
refractory to Con A stimulation. 
This study was attempting to obtain an enriched NK cell population through 
the selective depletion of other lymphocytes (negative selection). Athough the 
panning technique generally produced a reasonably pure adherent population, it was 
never possible to totally deplete the non-adherent population of any particular type of 
lymphocyte, regardless of which monoclonal antibody was used. It was therefore 
concluded that panning was not the ideal cell separation technique with regards to 
this study, and so magnetic bead separation was attempted instead. 
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2.4.4 Enrichment / Depletion of Cell Populations by Magnetic Bead 
Separation. 
Immunomagnetic separation is becoming increasingly popular as a means of 
cell separation or cell enrichment, due to the variable ways it can be employed (direct 
or indirect, positive or negative selection - Funderud et al. 1987), and because of the 
excellent results it achieves. For example. Hansel et al. (1989) found that negative 
immunoselection on human blood produced eosinophils of greater purity and activity 
than those purified by other techniques they had attempted. Furthermore, such 
negative selection had no eflFect on the functionality of the resulting lymphocyte 
populations (Funderud et ai, 1987). Consequently, negative immunoselection of 
Xenopus lymphocytes was attempted via the indirect method, where cells are first 
sensitised with monoclonal antibody, and then magnetically separated with 
Dynabeads® coated with anti-Ig. 
As with the panning experiments, initial trials attempted to remove B cells 
with the mAb 8E4, and required several modifications to determine optimum 
conditions. This series of magnetic cell separation experiments successfully 
determined the optimum conditions required for B cell depletion / enrichment of T 
cells, and these were as follows:- a) incubation of cells in 0.5ml of 8E4 at a 1 in 4 
dilution, b) separation with a bead : cell ratio of 10; 1, c) washing of adherents 
before removing them to culture, and d) overnight (17 hour) culture of populations 
before utilisation. 
Following these optimum conditions, T cell removal was attempted using the 
mAb 2B1. Initial experiments using 2B1 at concentrations of 1 in 5 and 1 in 10 were 
extremely successful, reducing 261" contamination in the non-adherent population to 
only minimal levels. Considering the large proportion of T cells that are present in 
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control animals, this is a highly effective technique for efficient T cell removal, and 
one that achieves far superior results than panning. This is in agreement with a 
review by Funderud et ai (1987) which cites very efficient depletion of T cells using 
both direct and indirect methods. Such good T cell depletion is beneficial because it 
allows a 'non-T cell' population to be generated (on which further separations can be 
made) without using up precious thymectomised animals. 
Subsequent removal of T cells was attempted using AM22, a | i isotype 
antibody that recognises the CD8 antigen (Flajnik et al, 1990). It was expected that 
separation might be very poor since the anti-Ig attached to the M-450 Dynabeads® 
recognises chiefly immunoglobulin of the y isotype (and loosely the \i isotype -
Dynal® product information guide), and therefore binding might not be strong enough 
to pull out the cells. However, beading managed to successfully remove about half of 
the CD8^ population. 
On comparison of the two cell separation techniques investigated in this 
study, it was found that both panning and magnetic bead separation were able to 
deplete a splenocyte culture of B cells to the same extent, but that magnetic sorting 
produced far superior results for depletion of T cells. Furthermore, immunomagnetic 
separation had proved to be a much simpler and less time consuming technique than 
panning. Although it was not tested here, other workers have found that the 
functionality of the non-adherents is unaffected by the beading procedure (Funderud 
et al, 1987). (Perhaps an additional experiment could be performed to confirm this 
with Xenopus lymphocytes by treating the resultant populations with Con A and LPS 
and assessing the stimulation in ^HTdR assays, as was performed for panning). 
Consequently, immunomagnetic separation utilising Dynabeads® M-450 was selected 
as the technique for generating enriched populations for further analyses. 
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2.4.5 Assessment of the Killing Activity of Cell Populations 
Enriched by Magnetic Bead Separation. 
Although spontaneous cytolytic activity of allogeneic tumour cells had already 
been observed in Xenopus (see section 2.3.2), the specific cell population responsible 
for the activity had not been identified. Thus, in an attempt to locate this activity, 
control cells (from a Xenopus that had been primed with B3B7 tumour cells to boost 
the level of NK cells) were subjected to immunomagnetic separation under optimum 
conditions using either 2B1 or 8E4, and then assessed for their cytolytic activity 
against B3B7 cells in ^ 'Cr-release assays. 
Interestingly, the least spontaneous cytotoxicity was exhibited by the 2B1 
adherents which were almost pure T cells (2Br), suggesting that T cells are not 
responsible for such 'natural' killing. In comparison, the other 'less pure' 
populations ('unseparated', 2B1 non-adherents' and '8E4 non-adherents') all 
exhibited a much higher cytolytic ability. Interestingly, removal of either 2Q\^ or 
8E4^ cells from the splenocyte culture results in an elevated level of cytotoxicity, with 
depletion of 8E4^ cells resulting in the highest. This increase in killing in the non-
adherent populations compared to the unseparated populations may be due to the 
removal of cells which do not contribute to natural killing, and thus the relative 
enrichment of 'killing' cells in the remaining sample (at the same E : T ratio). Had 
time allowed, it would have been interesting to assess the cytolytic activity of 
magnetic bead separated populations from thymectomised animals. 
From these preliminary studies, it can be therefore be postulated that the 
lymphocytes responsible for natural killer activity in Xenopus are likely to be a 'non-
T, non-B' lymphoid subset, which agrees with numerous studies on mammalian 
natural killer cells (see review by O'Shea and Ortaldo, 1992). In order to locate 
more specifically the natural killer cell population, monoclonal antibodies specific for 
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Xenopus natural killer cells are required. Since there is no mAb to Xenopus NK cells 
as yet, it might have been interesting to attempt isolation using the 5C6 mAb, a 
mouse mAb raised against catfish NK-like cells by Evans et al. (1988). This mAb is 
believed to identify receptors on human NK cells, but it's suitability to probe 
Xenopus NK-like cells has recently been questioned (Horton et al, 1996), especially 
as it binds a high proportion of Xenopus B lymphocytes. 
The preparation of antibodies against Xenopus NK cell surface antigens is 
now clearly required. One method being considered in this laboratory is to use phage 
display technology for this purpose. In Chapter 3, preliminary molecular biology 
experiments, necessary to establish such technology, are outlined. 
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Chapter 3 
Preliminary investigations into the 
development of Thage Display' technology 
for the generation of scFv fragments 
3.1 Introduction 
One of the long-term goals of natural killer cell study is to identify and 
characterize the cell surface markers that are involved in the recognition, binding and 
activation of the natural killer cells. Such a characterization would then allow a 
greater understanding of the mechanisms by which natural killer cells operate, and 
hence could potentially be exploited for therapeutic benefit. However, identifying 
cell surface markers, especially those which are involved in the killing activity of the 
cell, can prove difficult. One method of approaching this problem is to generate 
antibodies against the surface markers, and then to characterize these antibodies, 
identify what they bind to, and use them to modulate the activity of the surface 
markers. Such generation of antibodies is currently being attempted using the 
technique of 'phage display' (discussed in greater detail later), which mimics 
antibody production in the natural immune system. 
In nature, organisms generate sufficient antibodies to recognize and combat 
any antigens that they might encounter during their lifetime, a number which far 
exceeds the number of genes available to code for them. This puzzling situation has 
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been solved by the discovery of several mechanisms that generate extra diversity from 
the genetic material available (reviewed by Hay (1989); Stryer (1988); Alberts et. al. 
(1989) and Mathews & van Holde (1990)):-
Antibodies (or immunoglobulins) are basically comprised of two identical 
heavy chains and two identical light chains linked together by disulphide bonds, and 
each chain contains both a variable domain and one or more constant domains 
(Figure 3.1). The first mechanism of generating diversity is that these variable and 
constant domains are encoded by separate segments of DNA with one or a few genes 
coding for the constant domain, and a very large number (several hundred) of genes 
coding for the variable domain. These different segments of DNA (which are often 
quite far apart in the germ line) are brought together during the development of a 
fially diflferentiated B cell, such that any one ' V gene becomes joined to one ' C 
gene. 
Figure 3.1 : The basic structure of an immunoglobulin (IgG). (Taken from Roitt et 
al, 1989) 
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Diversity is further increased by the fact that the variable domain is not 
encoded completely by the 'variable' (V) genes. Instead, the last few amino acid 
residues are encoded by one of five 'joining' (or 'J') genes in the light chain, and by 
one of five 'J' genes plus one of fifteen 'diversity' (or 'D') genes in the heavy chain. 
These last 'J' and 'DJ' segments make an important contribution to diversity because 
they encode part of the last hypervariable region, which is involved in antigen 
binding. Mechanisms exist to ensure that like segments do not join, and that different 
segments join in the correct order, i.e. V genes are joined to J genes which are joined 
to C genes in light chains (and V to J to D to C in heavy chains). However, the 
accuracy with which joining occurs is not particularly precise, meaning that the same 
V and J genes could create three different amino acid sequences. This is known as 
recombinational inaccuracy. Finally, heavy chain genes are on different chromosomes 
to light chain genes, such that any light chain can combine with any heavy chain 
(therefore 10"* different light chains capable of binding with 10* heavy chains would 
generate 10^  different binding specificities). Added on to all these mechanisms, the 
fact that cells undergo somatic point mutation and change their amino acid sequence, 
and it is easy to see that nature has developed a complex and sophisticated process 
for generating vast antibody diversity. 
Following their production, these antibodies circulate in the body until they 
contact antigen and are stimulated into proliferation. During this stimulation, further 
somatic mutation occurs which potentially generates antibodies of a higher affinity. 
Due to Darwinian selection over repeated cycles of antigen selection and somatic 
hypermutation, these higher affinity antibodies will be selected to survive in a process 
known as affinity maturation. Thus, from a limited pool of genetic material, nature 
can generate highly specific antibodies to what may be even rare antigens. Such a 
capacity would be extremely useful in scientific investigations and thus researchers 
are currently attempting to imitate these natural processes using 'phage display' 
technology. As an insight into how scientists have attempted to achieve this, a brief 
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history of the development of the technology is now given. (Reviewed by Nissim et. 
al. (1995), Winter et. al. (1994), Irving et. al. (1996) and Winter & Milstein (1991). 
Original techniques for generating monoclonal antibodies involved 
'hybridoma technology', in which antibody-producing cells were fused to myeloma 
cells, making them immortalized hybridoma cells, each one secreting homogenous 
antibody of a desired specificity. (Discovered by Milstein and Kohler in 1975 - see 
Stryer, 1988). As in the natural immune system, somatic cell mutation allowed some 
diversity to be generated, but the antibody repertoire was somewhat restricted, 
especially against self-antigens. The advent of gene technology began to change this 
because it meant that antibody genes could be manipulated and altered in vitro 
(Winter and Milstein, (1991) and references therein). 
Initially, rearranged antibody genes were amplified from the hybridomas 
(using the polymerase chain reaction), cloned into plasmid vectors and expressed first 
as complete antibodies in mammalian cells (Winter and Milstein review (1991)), and 
then as antibody fragments in bacteria. For example, Skerra and Pluckthun (1988) 
demonstrated that the Fv fragment of McPC603 (a monoclonal antibody against 
phosphorylcholine) could be produced in Escherichia coU. This Fv fragment was 
functional and had an identical affinity constant to the native McPC603. Their 
technique mimicked the assembly pathway of antibodies in eukaryotic cells, in that 
transport of the two variable domains (VH and VL) into the periplasmic space of E. 
coU (and their subsequent association) is fijnctionally equivalent to the transport of 
the immunoglobulin chains into the lumen of the endoplasmic reticulum in eukaryotic 
cells (and their subsequent assembly into a whole antibody). 
Although these soluble antibody fragments secreted from the bacteria could 
then be screened for binding activities, it was hypothesised that screening, especially 
for antibodies against rare antigens, would be greatly facilitated i f the Fv fragments 
could be expressed on the surface of bacteriophage (phage) i.e. 'phage display'. In 
1990, McCaflferty et. al constructed a single chain Fv fragment (scFv) of the anti-
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lysozyme antibody D l .3 by joining the VH and VL domains with a flexible linker (Gly4 
- Ser)3. This construct was cloned into an Fd phage vector at the amino terminal end 
of the gene I I I minor coat protein (3 or 4 copies of which are usually expressed at the 
tip of the phage), such that an antibody - gene I I I fusion protein was produced, 
anchoring the scFv protein to the outside of the phage coat. They then demonstrated 
that this 'phage antibody' bound specifically to lysozyme (with an affinity similar to 
that of the parent D1.3 antibody), and that affinity chromatography using lysozyme-
Sepharose was capable of isolating rare phage (one in a million) through binding 
between the lysozyme and the displayed scFv D1.3 fragment. 
Developing this technique fijrther, the use of hybridomas as a starting point 
was superseded by the cloning of antibody genes directly from the lymphocytes of an 
immunized animal (Huse et. ai, 1989). The advantages of using such a 
heterogeneous cell population are that the repertoire of potential genes is much 
greater than in hybridomas and it mimics the natural immune system much more 
closely. Kang, Burton and Lerner (1991) used PCR to obtain the Fd (VH + CHI) and 
light chain genes from mouse spleen R N A , cloned them into separate "k expression 
vectors, (generating separate heavy and light chain libraries, just as the natural 
immune system has separate 'pools' of heavy and light genes), and then combined 
them randomly to generate single X vectors containing one heavy and one light gene. 
This process (which produces fijnctional antibodies that are found in the lysed 
bacteria of the phage plaque) mimics exactly the random shuffling of heavy and light 
chains that is used to generate diversity in nature. However, only 0.1 - 1% of the 
combinations could be accessed by screening. 
Thus, Kang, Barbas et. al. (1991) went on to develop a more powerful 
technique for accessing these very large combinational libraries. Instead of using 
phage X, they used the filamentous Ml3 bacteriophage which is related to Fd phage. 
In this system, Fd (VH +CHI) is fiised to gene VII I (the major coat protein of M13 
phage, with approximately 3000 copies per phage particle), such that several copies 
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of Fd become anchored along the entire length of the phage surface. The 
concomitant secretion of K light chains into the periplasm allows functional Fab 
molecules to assemble and through binding to antigen, relevant phage can be 
selected. Each phage displays a single antibody species (Winter et. al., 1994), and 
contains all the genetic material needed to code for that antibody, just as B-cells do in 
nature. Since M l 3 display multivalent Fabs, a wider range of affinities is able to be 
captured. Furthermore, since all the genetic material is present, the pool of selected 
antibodies can be mutated and further selected, or exposed to limiting amounts of 
antigen, such that higher-affmity antibodies (and the genes for them) are generated. 
This process is akin to affinity maturation in the natural immune system. 
Finally, the systems used have been engineered to mimic the plasma cell in 
producing soluble antibody fragments (Irving et. al., 1996; Winter et. al., 1994). To 
do this, amber stop codons have been incorporated at the site between the antibody 
fragment and the coat protein (pIII or pVIII). When the phage is grown in 
suppressor bacteria, the amber codon is supressed, the fragment becomes fused to the 
coat protein and is displayed on the surface. When the phage is grown in wild type 
bacteria, the amber codon is functional and the antibody fragment is secreted. Thus, 
technology has developed to imitate almost every stage of antibody production. 
(Figure 3.2). Furthermore, phage selection appears to be at least as powerful as 
immune selection. 
In this study, generation of recombinant antibodies (scFv fragments) was 
attempted using a modified M13 system (also developed in Kang's laboratory -
personal communication). The details of the procedure are discussed in greater depth 
later (see section 3.4), but in brief the technique involves immunization of mice with 
the relevant antigen (to boost levels of the appropriate V-gene repertoire), 
amplification of the heavy and light chain domains (generating 'pools' or libraries of 
different V genes), random combination of heavy and light chain genes (mimicking 
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natural random association) and selection of high affinity fragments through repeated 
rounds of antigen-selection and mutation (mimicking natural affinity maturation). 
In order to learn the technique, and to simplify the results, initial experiments 
were performed using a single antigen - Carboxypeptidase Y. The aim was, that 
having perfected this technique on the CPY, the study would move on to generating 
antibodies against a cell population, and for this, the B3B7 Xenopus thymic tumour 
cell line was chosen. However, ultimately the aim was to immunize mice using pure 
natural killer cell populations (or at least the NK - enriched populations generated 
through the beading experiments detailed in Chapter 2), such that monoclonal 
antibodies could be generated against the natural killer cell surface markers. 
Unfortunately, neither time nor the success of the initial experiments allowed this 
goal to be realized, but it is still feasible for further study. 
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Figure 3.2 : Generation of antibodies by the immune system and phage technology. 
Steps : ( I ) rearrangement or assembly of germline V genes; (2) surface display of 
antibody (fragment); (3) antigen-driven or aflfmity selection; (4) affinity maturation; 
(5) production of soluble antibody (fragment). 
(Taken directly from Winter, Griffiths et. al., 1994) 
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3.2 Materials and Methods 
3.2.1 Preparation of Oligonucleotides 
Oligonucleotide primer pellets (prepared by John Gilroy, Department of 
Biological Sciences, University of Durham on ABI) were resuspended in 1ml sterile 
water, and their concentration determined by measuring their optical density at 
260nm (OD260) (Samples were measured as a 1 in 20 dilution in distilled water, and 
blanked against distilled water). 
Since OD260 1.0 = 33 \x§/m\ for an oligo, 
concentration of oligo = OD260 x 33 x 20 ]xg/m\. 
3.2.2 Immunisation of Mice 
Two Balb c mice were used in each immunisation. 300^1 PBS containing 
either SOjag Carboxypeptidase Y or 10^  B3B7 cells was injected intraperitoneally at a 
single site. Each animal was boosted with the same antigen (in 300|il PBS) 14 days 
later, and then killed a further 14 days later. 
3.2.3 Removal of Spleen and Blood from Mice 
All dissection equipment and eppendorfs had been pre-treated with either 
RNAse-away or DEPC-water to remove any contaminating RNAses. Mice were 
anaesthetised by P. Hunter using ether. The spleen was then dissected out ventrally 
by M. D. Watson, transferred to a sterile 1.5ml eppendorf, and placed immediately on 
ice while the blood was being obtained. Blood was obtained by cardiac puncture 
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using a 2ml syringe and a 19-gauge needle (performed by P. Hunter). This was also 
transferred to a 1.5ml eppendorf and placed on ice. 
I f RNA extraction from the spleen was to be delayed for any reason, the 
spleen was then frozen and stored at -80°C until ready for use, otherwise, extraction 
was performed immediately. RNA extraction was performed using either the Scotlab 
Nucleon, Pharmacia, or Stratagene extraction kits according to the manufacturers 
instructions (see sections 3.2.5, 3.2.6 and 3.2.7 respectively). 
3.2.4 Preparation of anti-serum from the Blood 
The blood was placed in a 37°C heat block (Grant Instruments BT3) for 
approximately 3 hours to help it to clot. Then it was centrifuged for 20 minutes, at 
fijll speed in a bench-top microcentrifuge (Hettich Mikroliter), and the supernatant 
(anti-serum) was removed to a sterile 1.5ml eppendorf. Sodium azide was added as a 
preservative to a final concentration of 0.1% v/v., and the samples were stored at 
-20°C until use. 
3.2.5 Scotlab N U C L E O N R J V A Extraction Kit 
All equipment was pre-treated with either RNAse-away or DEPC-water to 
remove any contaminating RNAses. The spleen was first chopped up into small 
pieces using a sterile scalpel, before being transferred to an homogeniser and 
homogenised in lysis solution. The rest of the protocol was performed according to 
the manufacturers instructions, except in section CI.2 of the Quicktrack RNA 
method. (Here, the alteration was to place the RNA-containing supernatant at -20°C 
for 40 minutes, then to centrifijge at J0,000g for 20 minutes at 4°C). Finally, the 
RNA pellet was resuspended in 100|al RNAse - free water and stored at -20°C. 
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3.2.6 Pharmacia RNA Extraction Kit 
All equipment was pre-treated with 'RNAse-Away' or DEPC-treated water 
to remove any contaminating RNAses. After weighing, the spleen was chopped into 
small pieces with a sterile scalpel, transferred to an homogeniser and homogenised in 
extraction buffer (18ml/g tissue). The homogenate was then filtered through sterile 
glass wool (instead of centrifijging at SOOOg for 20 minutes at 15°C, as this had been 
attempted and found to be ineffective), and then passed through a 19 gauge needle 20 
times to shear the DNA. Ultracentrifijgation of the sample was performed in a 
Beckman SW28 rotor for 16 hours, and then the RNA was recovered as described in 
the manufacturer's instructions, including the ethanol precipitation step. (RNA was 
stored at -20°C). 
3.2.7 Stratagene RNA Extraction Kit 
All equipment was pre-treated with 'RNAse-away' or DEPC-treated water to 
remove any contaminating RNAses. After weighing, the spleen was either chopped 
up with a sterile scalpel and then homogenised, or pierced several times with a sterile 
needle and syringe and flushed with PBS until all the cells were out, and the spleen 
appeared 'white'. The rest of the protocol, which included a phenol : chloroform 
extraction and an ethanol precipitation, was followed exactly as per the 
manufacturers instructions, with no alterations. The RNA pellet was resuspended in 
DEPC-treated water and stored at -20°C. 
3.2.8 Assay of RNA 
RNA quality was assayed by spectrophotometry. A small aliquot (usually 
5|il) of the RNA preparation was diluted 20 fold with sterile, DEPC-treated water, 
and it's absorbance at 260nm measured on a spectrophotometer which had been 
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blanked against distilled water. Each sample was measured for it's absorbance at 
260nm ( A 2 6 0 ) and it's ratio of absorbance at 260nm to absorbance at 280nm 
(A260 /A280) . Each sample was also measured three times so that an average recording 
could be calculated. 
3.2.9 1st Strand cDNA Synthesis 
A reaction mix of 5^1 total RNA, 3|il primer (either MVH-link or DB3 
BLAB) and 6|il DEPC-treated water was incubated at 70°C for 10 minutes, then on 
ice for at least 1 minute. To this was added (from the BRL Superscript Pre-
amplification Kit) 2|al 10 x PCR buffer, 2|il 25mM MgCb, lOmM dNTP, 2|il 
0. I M DTT, and l | i i Superscript I I Reverse Transcriptase. On a Techne PHC-3 
thermal cycler, this mixture was then incubated at 26°C for 10 minutes, 42°C for 50 
minutes, and 70°C for 15 minutes, then 4°C for at least 1 minute before the addition 
of l | i l RNAse H (from kit) and a fijrther incubation of 20 minutes at 37°C. This was 
stored at -20°C until use. 
3.2.10 Polymerase Chain Reaction (PCR) 
PCR reactions were performed in a thermal cycler (PHC-3, Techne). 
Typically, each reaction contained ca.60 pmoles of each primer (detailed in Appendix 
A), 20 nmol of each dNTP, 1.5mM MgCh PCR buffer (provided with the enzyme) 
and 1 unit of Taq DNA Polymerase (Gibco-BRL) in a final volume of lOOfil in a 
0.5ml microcentifuge tube / eppendorf. The quantity of template in each reaction and 
the cycling conditions varied according to what was to be amplified, and are therefore 
described where individual PCR reactions appear in the results chapter. Taq 
polymerase was the last component to be added to the reaction before mixing by brief 
centrifugation. The reaction mixture was then overlaid with 100|j.l sterile mineral oil 
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to prevent evaporation during the heat cycles. After completion of the PCR, samples 
were stored at 4°C until ready for analysis by agarose gel electrophoresis. 
3.2.11 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was performed in either a Biorad (50ml) or 
Appligene (80ml) mini-gel system. Agarose powder (Gibco BRL) was added to the 
appropriate volume of 1 x TAE buffer (usually to a concentration of 2% w/v, but this 
was varied according to the size of DNA to be separated) and dissolved by 
microwaving. (50x TAE = 242g TRIS, 57.1ml glacial acetic acid, 100ml 500mM 
EDTA pH 8.0). After allowing this to cool, ethidium bromide was added to a final 
concentration of 0.5\xg/m\, and the mixture was poured into a gel mould containing a 
well-former. This was left to set before being transferred to an electrophoresis tank 
and covered with 1 x TAE buffer containing 0.5|ig/ml ethidium bromide. Molecular 
weight markers and DNA samples in loading buffer were loaded into separate wells, 
and electrophoresis was performed until the dyes had migrated an appropriate 
distance (For a 2% gel this was usually 90V for 1% hours). The gel was then 
photographed on a UV illumination apparatus, using a red filter and a Polaroid 
camera. 
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3.3 Results 
3.3.1 Amplification of Kappa Chains 
Initial experiments were performed on spleens from mice that had been 
injected with 300|il of PBS containing 50]xg Carboxypeptidase Y (CPY), so that 
optimum conditions could be could be determined before using precious Xenoptis 
lymphocytes. 
Thus, two Balb c mice were injected with CPY, boosted 14 days later under 
the same conditions, and then had their spleens and some blood removed a flirther 14 
days later as described in section 3.2.3. Both spleens were frozen at -80°C. Two 
days later, one of the spleens was removed from storage, weighed (140mg), and an 
RNA extraction was performed on it using the Nucleonj^j ,^^  Test Kit (as described in 
section 3.2.5.), storing the pellet at -20°C overnight. 
l^t strand cDNA synthesis was performed on this RNA using the DB3-BLAB 
primer to obtain the Kappa chain cDNA, Six reaction mixtures were then prepared 
for PCR, each one containing 2iil of the DB3-BLAB cDNA and 3|il of one of the 
light chain primers (O.ljig/ml), before being treated to 91°C for 1 min 15 sec and 
72°C for 1 min 30 sec, ending at 4°C until ready for use. 10|al of each PCR product 
was then analysed by agarose gel electrophoresis (2% agarose, Biorad), and the 
results are shown in Figure 3.3. As Figure 3.3 demonstrates, nothing could be seen 
on this gel, not even any of the primers, which suggested that the primer working 
solutions were too dilute for amplification to work. Consequently, different diluUons 
of the light chain primers were analysed by agarose gel electrophoresis, and it was 
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found that only the 'stock' primers were visible on the gel (results not shown), and 
therefore only these primers were suitable for amplification purposes. 
Thus, a repeat PCR was set up, following the same conditions as just 
described except that the stock primers (variable concentration) were used instead of 
the 0.1|ag/ml dilution. However, although there was a row of primers just visible at 
<100bp, there were no amplification bands present at all (expected at ca. 660bp) -
results not shown. Given that all the light chain primers were visible, it was thought 
that the problem could have been with either the DB3-BLAB or the RNA, and so 
both were analysed by agarose gel electrophoresis (2% agarose, Biorad, 10|al total 
RNA, and 5^1 stock DB3-BLAB). Figure 3.4 quite clearly shows a 'streak' of 
sample in the RNA lane (lane 3), which is characteristic of RNA, while nothing is 
visible in the DB3-BLAB lane (lane 7), suggesting that it is the DB3-BLAB primer 
that is the problem. 
Fortunately, a second sample of DB3-BLAB primer was available (used 
successfiilly by M. D. Watson in The Scripps Institute, San Diego), and so another 
repeat T' strand cDNA synthesis and Kappa PCR amplification was performed using 
this second sample (all other conditions the same). Unfortunately the experiment was 
again a failure, with no bands visible other than the primer bands at <100bp (results 
not shown). It was thus suspected that this DB3-BLAB was no good either, and had 
deteriorated over time. However, when it was analysed by agarose gel 
electrophoresis, it was quite visible with the other light chain primers (Figure 3.5, all 
stock solutions), and hence should be working fine. Given that all the primers were 
not a problem, and that RNA was present, it was hypothesised that it must, in fact, be 
the quality of the RNA which was poor. For instance, the RNA present may be in 
small fragments, such that the complete template region necessary for amplification is 
not intact, and therefore it would be impossible to amplify up the light chain genes 
successfully. Consequently, it was decided to extract the RNA from the second 
'CPY' spleen using a different technique. 
117 
RNA extraction from the spleen (which weighed 120mg) of the second mouse 
injected with Carboxypeptidase Y was thus attempted using the Pharmacia RNA 
extraction kit (see section 3.2.6 for details), and the resulting sample assayed by 
agarose gel electrophoresis. Figure 3.6 demonstrates that the technique was clearly 
successfijl at producing a good RNA preparation, since the RNA sample is now 
readily visible on the gel, and the smear is very long, covering a wide range of 
molecular weights (unlike the Nucleon-prepared RNA which only appears at the 
lower molecular weights - less than 200 or 300 bp long - see Figure 3.4). 
Thus, 1st strand cDNA synthesis was performed on this new RNA (using 2|j.l 
of the stock San Diego DB3 BLAB primer), and then the light chains were amplified 
up using the same PCR conditions as last described (using 2\x\ of the stock DB3 
BLAB and Lc primers). 10^1 of each PCR product was analysed by agarose gel 
electrophoresis, and the results are shown in Figure 3.7 . Faint bands were visible for 
Lc3 and Lc7 (tracks 5 and 13 respectively) at approximately 660bp, while even 
fainter bands were just visible at the same molecular weight for Lc l , Lc4 and Lc6 
(tracks 3,7 and 11 respectively). Consequently, it was decided to opfimise the 
conditions from these promising results by adjusting the annealing temperature during 
the PCR cycle. 
For convenience, only two samples were chosen for the adjusted amplification 
- Lcl (which had previously appeared as a faint band) and Lc3 (which had previously 
appeared as a faint clear band). The reaction mixture was prepared exactly as last 
described, but the cycling conditions were altered to either +3°C or -3°C on the 
annealing temperature. 
I.e. +3°C; 91°C 
91°C 
55°C 
72°C 
4°C 
1 min 
1 min 15 sec 1 
1 min 15 sec }• 
1 min 30 sec J 
35X 
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-3°C 91°C 1 min 
9 r C 1 min 15 sec 1 
49°C 1 min 15 sec } 35X 
72°C 1 min 30 sec J 
4°C 
10|^ l of each of the four PCR products was then analysed by agarose gel 
electrophoresis, and the results are shown in Figure 3.8 . There are no bands present 
for Lc l at either of the adjusted temperatures, but there are bands cleariy visible for 
Lc3 (at ca. 650/700bp) at both temperatures. The strongest Lc3 band is at +3°C, i.e. 
when the annealing temperature was increased by 3°C to 55°C. Consequently, a 
PCR was performed for all the Kappa light chains at +3°C annealing temperature, (all 
other conditions were the same as last described) and the products analysed by 
agarose gel electrophoresis. When the gel was viewed under the ultra-violet light, 
definite bands at ca. 660bp could be seen for Lc3, 4, 5 and 7 (tracks 5, 7, 9 and 13 
respectively), with Lc3 being by far the strongest. However, these bands are not 
quite so clear on the polaroid photograph of the gel (see Figure 3.9). No bands were 
visible for Lcl or Lc6 (tracks 3 and 11 respectively), although it is possible they were 
there, just extremely faint. 
Given that bands were visible in most samples, an attempt was made to 
increase the amount of amplified product present by increasing the amount of total 
RNA used in the first strand cDNA synthesis, (i.e. increasing the amount of template 
available). Thus, 8^ x1 total RNA (instead of 5[i\) was mixed with l | i l DB3 BLAB 
primer, (the DEPC-treated water being used to adjust the volume), and the rest of the 
protocol was performed as described in section 3.2.9. As a trial PCR amplification of 
this cDNA was first only attempted for Lc l , 3 and 4. PCR was performed at +3°C 
annealing temperature, all other conditions being as previously described. 10|al of 
each of these PCR products was analysed by agarose gel electrophoresis (2% 
agarose, Biorad), and the results (shown in Figure 3.10) were found to be the best 
produced so far, with very clear, distinct bands visible for both Lc3 and Lc4 (tracks 5 
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and 7 respectively) at ca. 700bp, Consequently, the first strand cDNA synthesis and 
PCR was repeated for the remaining Kappa light chains (Lc5, 6 and 7), except that 
the amount of total RNA used in the cDNA synthesis was again increased, to 10|al. 
As Figure 3.11 demonstrates, bands were visible in all three samples at ca. 700bp, 
such that Lc3, 4, 5, 6 and 7 had all now been successfully amplified. 
However, the strength of the visible bands was still fairly weak, with not 
nearly the quantity of product present as had been obtained previously by M. D. 
Watson. It was considered still, that the problem lay in the quality of the RNA 
template, in that there was not enough good condition RNA of sufficient length to 
allow successful amplification. Consequently, RNA extraction was finally attempted 
using the Stratagene RNA extraction kit (used successfiilly by M. D. Watson and 
others in San Diego). Furthermore, the extraction was performed on fresh spleens, 
ie. directly they were taken from the animal, (rather than being stored at -80°C first. 
This was because other researchers had found that freezing the spleens to -80°C 
before extracting the RNA, significantly decreased both the quality and quantity of 
RNA produced (Chris Secombes - personal communication). 
As a trial, and simply to check that the extraction was successflil, initial 
experiments were carried out on spleens (both weighing 120mg) taken from 
unimmunised mice. Also, two different methods of cell extraction were tested - the 
first spleen was chopped up into small pieces and homogenised in the same fashion as 
had been performed with both the Nucleon and Pharmacia extraction kits, this 
preparation was termed the 'minced' sample. The second spleen was pierced several 
times with a needle, and then repeatedly flushed out with PBS, until the spleen 
appeared 'white'; this preparation was termed the 'pierced' spleen. RNA extraction 
was then performed on both of these samples using the Stratagene kit (see section 
3.2.7 for details). Each sample was then assayed for it's RNA quality/quantity, and it 
was found that the 'minced' sample had an average A260/A280 of 1.03, whereas the 
'pierced' sample had an average A260/A280 of 2.03 (Table 3.1). Given that the 
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Stratagene protocol states that the A260/A280 should be at least 1.7, this would 
suggest that the 'pierced' RNA sample alone is of a sufficiently high quality to be 
suitable for further use. The low A260/A280 ratio of the 'minced' RNA sample (which 
falls below the recommended level) may explain why the previous experiments have 
had only limited success - the rough chopping and homogenisation of the spleen may 
destroy some of the RNA, or cause it to fragment into small pieces. 
Although the results of the RNA assay suggested that only the 'pierced' RNA 
preparation would produce any useful results, both samples were used in separate 
first strand cDNA synthesis and PCR amplifications of the Kappa chains. lOjal of 
each total RNA preparation was used with l | i l DB3 BLAB in the cDNA synthesis; 
the rest of the protocol being as previously described (section 3.2.9). PCR 
amplification was only performed for Lcl and Lc3 in each case, and the annealing 
temperature was 55°C (i.e. +3''C from the original conditions). All other conditions 
were as previously described. \0[i\ of each PCR product was analysed by agarose 
gel electrophoresis (2% agarose, Biorad), and the results are shown in Figure 3.12. 
Bands were visible in all four samples - at ca 550bp for Lcl (both 'minced' and 
'pierced' - tracks 3 and 7 respectively), and at ca. 660bp for Lc3 (both 'minced' and 
'pierced' - tracks 5 and 9 respectively) - although the bands present in the 'pierced' 
sample are significantly more intense (hence more product) than those in the 'minced' 
sample (particulariy noticeable when comparing 'pierced' Lc3 - track 9 - with 
'minced' Lc3 - track 5). This is perhaps not surprising given that the 'pierced' RNA 
was of a much higher quality, and therefore there was 'more' template available for 
the PCR to work successfully. 
Consequently, this PCR was repeated under exactly the same conditions, 
except that only the 'pierced' RNA was used, for all the Kappa light chains. Figure 
3.13 illustrates the results of this experiment, and shows that bands are visible at ca. 
700bp for Lc3, 4, 5 and 7 (tracks 5, 7, 9, and 13 respectively), with particulariy 
strong bands for Lc4 and 5. There is a band present for Lcl (track 3), but at ca. 
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590bp it is perhaps a bit smaller than would be expected. No bands are visible for 
Lc6 (track 11), although it is possible that product is there - it just may be very faint. 
It is further likely that all of the bands could be made more intense (i.e. increasing the 
amount of PCR product present) by adjusting various conditions and concentrations. 
However, at this point it was decided to leave the conditions as they were, and to 
attempt amplification on the experimental spleens, which may contain a higher titre of 
antibodies anyway. 
Finally, amplification was attempted on spleens from two mice that had been 
injected with B3B7 Xeriopus thymus tumour cells. Splenocyte preparations were 
produced by piercing the spleens, and RNA was extracted using the Stratagene RNA 
extraction kit. Each sample was resuspended in 5Q\x\ of DEPC-treated water, and 
then the two samples were pooled. A spectrophotometric RNA assay of the pooled 
samples showed an average A260/A280 of 1.9826 (Table 3.2), which is above the 
recommended 1.7 for suitable quality RNA. Thus, first strand cDNA was synthesised 
from this RNA, using 10|il total RNA and 1^ 1 DB3 BLAB - all other conditions 
being as previously described. PCR amplification was then performed for all the 
kappa light chains (at an annealing temperature of 55°C, i.e. +3°C, all other 
conditions as previously described), and the products were analysed by agarose gel 
electrophoresis. As Figure 3.14 quite clearly demonstrates, the experiment was 
extremely successful, with very intense bands present at ca. 700bp for Lc 3, 4, 5, 6 
and 7 (tracks 5, 7, 9, 11 and 13 respectively). Unfortunately, there were still no 
bands present in L c l , which suggested that maybe there were no anybodies of this 
particular type generated during the immunisation procedure. Thus it was established 
that the conditions used in this last experiment were the optimum for amplification of 
kappa chain genes, and hence these products were at a stage where they were ready 
for pooling and cloning to continue with the protocol. 
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3.3.2 Amplification of VH Chains 
Most of the initial experiments attempting to amplify the VH chains were 
performed alongside those for the kappa chains, and hence the details of and reasons 
for doing many of the VH experiments will not be given here - instead refer to section 
3 .3 .1. (Sometimes, for convenience, experiments were only performed for the kappa 
chains, and are therefore not described here for VH chains). Briefly, the results were 
as follows: 
RNA extracted (using the Scotlab NucleonRNA Test Kit) from the spleen of a 
mouse that had been injected with CPY, was subjected to first strand cDNA synthesis 
using the MVH-link primer (0.1|ig/ml) to obtain the VH chain cDNA. Nine reaction 
mixtures were then prepared for PCR, each one containing 2|il of the MVH-link 
cDNA and 3|j.l of one of the VH primers (0.1|ig/ml), before being treated to 91°C for 
1 min, and then cycled 35 times through 91°C for 1 min 15 sec, 48°C for 1 min 15 
sec, and 72°C for 1 min 30 sec, ending at 4'^ C until ready for use. Agarose gel 
electrophoresis of the PCR products revealed that the amplification had not worked 
since there were no bands visible (Figure 3.15). When the stock primers were 
analysed by agarose gel electrophoresis, it was found that all the primers were 
present and visible, and therefore should not be the cause of the problem. 
Consequently, RNA from the second 'CPY' spleen was extracted using the 
Pharmacia RNA extraction kit, which generated lots of RNA (refer to Figure 3.6). 
First strand cDNA was synthesised as first described, with 5^1 total RNA, and PCR 
amplification was performed for all nine VH primers (using 2|j.l of each stock primer, 
all other conditions being as previously described). Unfortunately, no bands of the 
expected length - ca. 440bp - were visible (see Figure 3,16). Instead, there was a 
mixture of bands present :- at ca. 290bp for He 1, 3 and 7 (tracks 3, 5 and 9 
respectively), and at ca. 190bp for He 2 and 4 (tracks 4 and 6 respectively). 
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Although these bands were in the wrong position, it was more promising than none at 
all, and so an attempt was made to improve these results by adjusting the annealing 
temperature of the PCR by +3°C and +6°C (all other conditions as before). 
i.e. + 3 ° C : 9rC 1 min 
9rC 1 min 15 sec 
51°C 1 min 15 sec 
12°C 1 min 30 sec 
4°C 
+6°C : 9rC 1 min 
91°C 1 min 15 sec 
54°C 1 min 15 sec 
72°C 1 min 30 sec 
4°C 
For convenience, PCR was only performed on Hcl and Hc2 but, as Figure 
3.17 demonstrates, increasing the annealing temperature has no positive effects - in 
fact, the results are worse, with only vague bands for Hc2 at ca. 190bp, and nothing 
for H c l . P C R was thus attempted with an annealing temperature of 46°C, i.e. +2°C, 
but again the results were not as good as the original 48°C (a band is visible at ca. 
290bp in H c l , but it is slightly less intense at 46°C than 48°C - see Figure 3.18), and 
thus the rest of the experiments were annealed at 48°C. 
Given that the concentration of MgCb in the reaction buffer can be critical to 
the success of a PCR amplification, an experiment was performed to assess the effect 
of varying the MgCb concentration. Four reaction mixtures of Hcl were prepared, 
with either 1.5mM, 3.0mM, 6.0mM or 9.0mM MgCb. (All previous PCR 
amplifications have used 1.5mM MgCl2, which is the concentration in the supplied 
PCR buffer). The volume of water was adjusted in each reaction so that the final 
volume was still 100|^ 1, and all other conditions were as previously described. 
However, the experiment was again a failure, with no bands present whatsoever (not 
even at the wrong base pair length), results not shown. 
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At this point, relative success had been achieved with the kappa chains by 
increasing the amount of total RNA used in the first strand cDNA synthesis, and thus, 
this was attempted for the heavy chains too, increasing the amount of total RNA used 
to 10|al. PCR was performed on He 1, 2 and 3, using l.SmM MgCb and l|il stock 
primers, and the products were analysed by agarose gel electrophoresis. 
Disappointingly, increasing the amount of total RNA used did not improve the results 
(see Figure 3.19) - there are bands visible at ca. 290bp for Hcl and Hc3 (tracks 3 and 
9 respectively) which are not the bands required, and there are no bands present at all 
for Hc2 (track 5). 
Work then continued on spleens from unimmunised mice, with the RNA 
being extracted using the Stratagene kit, immediately after the spleen was removed 
from the animal. PCR amplification for all the He primers produced a mixture of 
different sized bands, most of which were the wrong size (Figure 3.20). However, if 
studied very carefijlly, a row of faint bands could be seen at ca. 440bp (i.e. the 
expected length), particularly in H c l , 3, 6 and 7 (tracks 3, 5, 7 and 8 respectively). 
Given that these were the most promising results produced so far, and given that 
even better results had been achieved for the kappa chains on the experimental 
spleens, it was decided to attempt V H amplification on the RNA from the B3B7-
injected mice. (See section 3.2.2. for details of RNA production). 
First strand cDNA was synthesised using 10|il total 'B3B7' RNA and 60 
picomoles of new MVH-link (synthesised by Perkin Elmer, 30 picomoles/|il), all 
other conditions being as previously described. PCR amplification was performed for 
all He primers under the original conditions described, except for the use of the new 
MVH-link (used 60 picomoles per reaction). As Figure 3.21 demonstrates, there is a 
clear band at approximately the correct position (400bp instead of 440bp) for Hc2 
(track 4), but unfortunately not for all the others. (Most of the others do have bands 
in them, but not at the correct length). Attempts were made to improve upon these 
results by both adjusting the annealing temperature and increasing the amount of He 
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primer used in each reaction. (It was postulated that the concentration of even the 
stock He primers was not sufficiently high to allow successfijl amplification). 
Consequently, PCR was attempted for all He primers, using 4^ 1 of the 
appropriate primer (adjusting the volume with the water), and annealed at either 
50°C, i.e. +2°C (Figure 3.22) or 56°C, i.e. +8°C (Figure 3.23). Agarose gel 
electrophoresis of all the PCR products revealed that neither of the experiments had 
been successfijl. Although there were several bands present, with particularly strong 
ones at ca. 290bp for He 3, 7 and 9 at both temperatures, there were no bands of the 
correct position (440bp) in any of the samples. These results were extremely 
disappointing, since at this point, all the kappa chains were successfijlly amplified and 
ready to pool. 
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Figure 3.3 : Agarose gel electrophoresis o f the Kappa chain PCR products 
obtained from the spleen of a mouse immunised with Carboxypeptidase Y. PCR was 
performed for all the Lc primers, at 0. l | ig/ml. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = L c l ; 
Lane 4 = Lc3; 
Lane 5 = Lc4; 
Lane 6 = Lc5; 
Lane 7 = Lc6; 
Lane 8 = Lc7. 
Positive picture Negative picture 
I 3 4 5 6 7 8 
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Figure 3.4 : Agarose gel electrophoresis o f the RNA extracted using the Scott 
NucleonRNA Test Kit from the spleen o f a mouse immunised with Carboxypeptidase 
Y; and o f the DB3-BLAB primer. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = RNA; 
Lane 7 = DB3 - B L A B (stock strength). 
Positive picture Negative picture 
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Figure 3.5 : Agarose gel electrophoresis of all the stock Lc primers and stock 
DB3-BLAB. 
Lane 1 = 100 bp molecular weight markers; 
Lane 3 = DB3 B L A B ; 
Lane 5 = Lc 1; 
Lane 7 = Lc3; 
Lane 9 = Lc4; 
Lane 11 = Lc5; 
Lane 13 = Lc6; 
Lane 15 = Lc7. 
Positive picture Negative picture 
3: 5 7 9 n B 15 
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Figure 3.6 : Agarose gel electrophoresis of the RNA extracted using the 
Pharmacia Kit from the spleen of a mouse immunised with Carboxypeptidase Y. 
Lane 1 = 100 bp molecular weight markers; 
Lane 2 = RNA. 
Positive picture Negative picture 
1 2 
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Figure 3.7 : Agarose gel electrophoresis of the Kappa chain PCR products 
obtained from the Pharmacia-extracted RNA of the CPY-injected mouse. 
PCR was performed with all the stock Lc primers and the 'San Diego' DB3 BLAB 
primer. 
Lane 1 
Lane 3 
Lane 5 
Lane 7 
Lane 9 
Lane 11 
Lane 13 
100 bp molecular weight markers; 
L c l 
= Lc3 
= Lc4 
= Lc5 
= Lc6 
= Lc7 
Positive picture Negative picture 
1 : 3 5 7 9 I I 13 
660 
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Figure 3.8 : Agarose gel electrophoresis of the L c l and Lc3 Kappa chain PCR 
products obtained with adjusted PCR annealing temperatures o f +3°C and -3°C from 
the original 57°C. 
RNA was extracted using the Pharmacia Kit from the CPY-injected mouse. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = L c l a t+3°C; 
Lane 5 = Lc3 at +3°C; 
Lane 7 = L c l a t - 3 ° C ; 
Lane 9 = Lc3 at -3°C. 
Positive picture Negative pcture 
1 3 5 7 9 
6 6 0 
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Figure 3.9 : Agarose gel electrophoresis of all Lc Kappa chain PCR products 
obtained at +3°C PCR annealing temperature (ie. 55°C). 
RNA was extracted using the Pharmacia Kit from the CPY-injected mouse. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = L c l ; 
Lane 5 = Lc3; 
Lane 7 = Lc4; 
Lane 9 = Lc5; 
Lane 11 = Lc6; 
Lane 13 = Lc7. 
Positive picture Negative picture 
I 3 5 7 9 11 n 
660 
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Figure 3.10 Agarose gel electrophoresis of the L c l , Lc3 and Lc4 Kappa chain 
PCR products obtained using increased amounts of RNA in the initial cDNA 
synthesis. 
8|al total RNA, Pharmacia-extracted from the CPY-injected mouse, was used instead 
o f the 5^1 used previously. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = Lc3; 
Lane 5 = Lc3; 
Lane 7 = Lc4. 
Positive picture Negative picture 
1 3 5 7 
660 
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Figure 3.11 : Agarose gel electrophoresis of the Lc5, Lc6 and Lc7 Kappa chain 
PCR products obtained using increased amounts of RNA in the initial cDNA 
synthesis. 
10|il total RNA, Pharmacia-extracted from the CPY-injected mouse,was used 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = Lc5; 
Lane 5 = Lc6; 
Lane 7 = Lc7. 
Positive picture Negative picture 
3 5 : 7 
6 6 0 
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Table 3.1 : Spectrophotometric assay of the RNA extracted using the Stratagene 
Kit from both 'minced' and 'pierced'/my/? spleens of unimmunised mice. 
Samples were blanked against distilled water, and their absorbance was measured 
three times, both at 260nm and 280nm. 
Source of RNA 
sample 
A260 A260 / A280 Average 
A260 / A280 
\ 
Minced spleen \ 
I 
2.3697 
2.3005 
2.8780 
0.9765 
1.0211 
1.1066 
1 
\ 1.0347 
J 
[ 
Pierced spleen "j 
I 
1.1811 
1.1822 
1.1850 
2.0258 
2.0371 
2.0235 
1 
\ 2.0288 
J 
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Figure 3.12 : Agarose gel electrophoresis of the L c l and Lc3 Kappa chain PCR 
products obtained from RNA that had been extracted using the Stratagene Kit from 
either minced or pierced //r'.v/7 spleens of unimmunised mice. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = L c l from a minced spleen; 
Lane 5 = Lc3 from a minced spleen; 
Lane 7 = L c l from a pierced spleen; 
Lane 9 = Lc3 from a pierced spleen. 
Positive picture Negative picture 
1 3 5 
6 6 0 
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Figure 3.13 : Agarose gel electrophoresis o f all Kappa chain PCR products obtained 
from Stratagene-extracted RNA from a fresh 'pierced' spleen of an unimmunised 
mouse. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = L c l ; 
Lane 5 = Lc3; 
Lane 7 = Lc4; 
Lane 9 = Lc5; 
Lane 11 = Lc6; 
Lane 13 = Lc7; 
Lane 15 = lOObp molecular markers. 
Positive picture Negative picture 
t : ;-:3 • ;:9.:. .H B S5 
660 
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Table 3.2 : Spectrophotometric assay of the RNA extracted using the Stratagene 
Kit from the 'pierced', fresh spleens of mice immunised with Xenopiis B3B7 tumour 
cells. 
Sample was blanked against distilled water, and it's absorbance measured four times 
both at 260nm and 280nm. 
Source of RNA 
sample 
A260 A280 A26O / 280 
Pierced spleens f 
of B3B7 - injected \ 
mice 1 
I 
0.5670 1.9914 1 
\ 1.9826 
1 
J 
0.5578 1.9739 
0.5514 1.9683 
0.5578 1.9667 
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Figure 3.14 Agarose gel electrophoresis of all Kappa chain PCR products obtained 
from Stratagene-extracted RNA from the fresh spleen of a mouse immunised with 
Xenopns B3B7 tumour cells. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = L c l ; 
Lane 5 - Lc3; 
Lane 7 = Lc4; 
Lane 9 = Lc5; 
Lane 11 = Lc6; 
Lane 13 = Lc7; 
Lane 15 = lOObp molecular weight markers. 
Positive picture Negative picture 
660 
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Figure 3.15 : Agarose gel electrophoresis o f all VH PCR products obtained from the 
spleen o f a mouse immunised with Carboxypeptidase Y. 
RNA was extracted using the Scott NucleonRNA Test Kit, and PCR was performed 
with 0. lug/ml primers. 
Lane 1 = lOObp 
Lane 3 = H c L 
Lane 4 = Hc2; 
Lane 5 = Hc3; 
Lane 6 = Hc4; 
Lane 7 = Hc5; 
Lane 8 = Hc6; 
Lane 9 = Hc7; 
Lane 10 = Hc8; 
Lane 11 = Hc9. 
Positive picture Negative picture 
3 4 - 5 : 6 8 . )^ !(> l i 
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Figure 3.16 : Agarose gel electrophoresis of all VH PCR products obtained using 
stock primers on Pharmacia-extracted RNA from the spleen of a mouse immunised 
with Carboxypeptidase Y. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = H c l : 
Lane 4 = Hc2 
Lane 5 = Hc3 
Lane 6 = Hc4 
Lane 7 = Hc5 
Lane 8 = Hc6 
Lane 9 = Hc7 
Lane 10 = Hc8 
Lane 11 = Hc9 
Positive picture Negative picture 
4 5 6 7 K 9 1011 
290 
' l 9 0 
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Figure 3.17: Agarose gel electrophoresis o f the H c l and Hc2 PCR products 
obtained with adjusted annealing temperatures o f +3°C and +6°C from the original 
48°C. 
RNA was Pharmacia-extracted from the CPY-injected mouse. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 - H c l a t + 3 ° C ; 
Lane 5 = H c l a t + 6 ° C ; 
Lane 7 = Hc2 a t + 3 ° C ; 
Lane 9 = Hc2 at +6°C. 
Positive picture Negative picture 
I 3 5 • : 7 9 
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Figure 3.18: Agarose gel electrophoresis o f the H c l and Hc2 PCR products 
obtained at both the recommended annealing temperature of 48°C, and at 46°C (ie. -
2°C). 
RNA was Pharmacia-extracted from the CPY-injected mouse. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = H c l a t 4 8 ° C ; 
Lane 5 = Hc2 at 48°C; 
Lane 7 = H c l a t 4 6 ° C ; 
Lane 9 = Hc2 at 46°C. 
Positive picture Negative picture 
I. :::3: 5: 7 9 
290 
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Figure 3.19 : Agarose gel electrophoresis o f the H c l , Hc2 and Hc3 PCR products 
obtained using increased amounts o f RNA in the initial cDNA synthesis. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = H c l ; 
Lane 5 = Hc2; 
Lane7 = Hc3. 
Positive picture Negative picture 
3 5 7 
290 
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Figure 3.20 : Agarose gel electrophoresis of all VH PCR products obtained from 
Stratagene-extracted RNA from a fresh 'pierced' spleen of an unimmunised mouse. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = He 1; 
Lane 4 = Hc2; 
Lane 5 = Hc3; 
Lane 6 = Hc4; 
Lane 7 = Hc5; 
Lane 8 = Hc6; 
Lane 9 = Hc7; 
Lane 10 = Hc8; 
Lane 11 = Hc9; 
Lane 13 = lOObp molecular weight markers. 
Positive picture Negative picture 
I 3 4 5 6 7 8 9 1011 B 
4 4 0 
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Figure 3.21 : Agarose gel electrophoresis of all VH PCR products obtained from 
Stratagene-extracted RNA from the fresh spleen of a mouse immunised with Xeuopus 
B3B7 tumour cells. 
Lane 1 = lOObp molecular weight markers; 
Lane 3 = H c l ; 
Lane 4 = Hc2; 
Lane 5 = Hc3; 
Lane 6 = Hc4; 
Lane 7 = Hc5; 
Lane 8 = Hc6; 
Lane 9 = Hc7; 
Lane 10 = Hc8; 
Lane 11 = Hc9; 
Lane 13 = lOObp molecular weight markers. 
Positive picture Negative picture 
3 4 5 6 7 9 10 i l B 
440 
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Figure 3.22 : Agarose gel electrophoresis o f all VH PCR products obtained using an 
increased amount o f each He primer and an adjusted PCR annealing temperature of 
50°C (ie. +2°C). RNA was Stratagene-extracted from the fresh spleen of a B3B7-
injected mouse. 
4|j,l o f each stock He primer was used, rather than ]|j,l 
Lane 1 = lOObp molecular weight markers; 
Lane 3 - H c l ; 
Lane 4 = Hc2; 
Lane 5 = Hc3; 
Lane 6 = Hc4; 
Lane 7 = Hc5; 
Lane 8 = Hc6; 
Lane 9 = Hc7; 
Lane 10 = Hc8; 
Lane 11 = Hc9; 
Lane 13 = lOObp molecular weight markers. 
Positive picture 
3 4 5 6 
Negative picture 
3 4 5 6 7 8 9 101 13 
440 
14S 
Figure 3.23 : Agarose gel electrophoresis of all VH PCR products obtained at an 
adjusted annealing temperature o f 56°C (ie. +8°C), from the Stratagene-extracted 
RNA from the fresh spleen o f a BjBT-injected mouse. 
4 | i l o f each He primer was used. 
Lane 1 = lOObp molecular weight maarkers; 
Lane 3 = H c l ; 
Lane 4 = Hc2; 
Lane 5 = Hc3; 
Lane 6 = Hc4; 
Lane 7 = Hc5; 
Lane 8 = Hc6; 
Lane 9 = Hc7; 
Lane 10 = Hc8; 
Lane 11 = Hc9; 
Lane 13 = 1 OObp molecular weight markers. 
Positive picture Negative picture 
i 3 4 3 6 7 B 9 10I I 13 
4 4 0 
14V 
3.4 Discussion 
In this study, the generation of recombinant monoclonal antibodies against 
natural killer cell surface markers was to be attempted through the use of 'phage 
display' technology. However, since this was a technique not attempted in our 
laboratory before, it was decided to trial the technology against a single antigen, 
Carboxypeptidase Y (CPY) first. Although antibody variable domain genes can be 
amplified from naive (i.e. unimmunised) sources, immunisation increases the number 
of cells producing an immune response, and therefore also increases the levels of 
mRNA encoding the specific immunoglobulins. (Winter et. a/., 1994; Clackson et. 
al, 1991). Thus, in each of our trials, mice were immunised with the relevant antigen 
(CPY or B3B7 cells) in an attempt to increase the chances of successflilly amplifying 
the relevant variable domains. Four weeks following the initial immunisation, the 
spleens were removed from the mice and the RNA was extracted from them. A 
series of different experiments confirmed that the best quality RNA was obtained i f 
extraction was performed on fresh spleens (i.e. immediately after removal from mice, 
and not frozen) using the Stratagene RNA extraction kit. Furthermore, better quality 
RNA was obtained i f the spleen was pierced and flushed out with PBS rather than 
minced and homogenised. (This latter technique was clearly too vigorous, resulting in 
fragmented RNA that was unsuitable for amplification). 
Once the RNA was obtained and reverse transcribed into cDNA, PCR was 
performed to obtain the variable heavy (VH) and kappa light chain genes. (Kappa 
light chains were chosen because less than 5% of murine antibodies posses lambda 
light chains - Roitt et. al., 1989. Therefore, by amplifying kappa chains, most 
antibodies should be represented). Fortunately, the constant regions flanking the 
murine variable domains have been well characterised (Irving et. al., 1996), allowing 
primers to these coding sequences to be designed. The primers used in this study 
were those detailed by Kang, Burton and Lerner (1991) (see Appendix A), with nine 
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5' primers for the heavy chain variable domains and six 5' primers for the kappa chain 
variable domains. In comparison, only one 3' primer is needed for the heavy chains 
(MVH - link) and one for the kappa chains (DB3-BLAB) because these primers are 
based on the sequence of the first part of the constant regions of the heavy and light 
chain genes. The M V H - link also includes the VH-CHI, elbow region which will act 
as a short linker sequence to join VH and kappa together to create a single chain Fv 
fragment (scFv). A similar construct was used by He et. al. (1995) to successfully 
generate an scFv fragment of the anti-progesterone monoclonal antibody DB3. See 
Figure 3.24. 
Figure 3.24 : Diagrammatic structures of monomer and dimer forms of scFv DB3 
fragments expressed in E. coli (taken from He et al, 1995) 
Fragment: 
1-$-
Domains: 3 
(ScFvs have been shown to have similar binding specificity and affinity to the 
parent antibody, and are also produced at higher levels than Fvs because they are 
produced as a single, fiased fragment, rather than having to associate in the bacterial 
periplasm - Irving et. al., 1996). Furthermore, each primer also contains a restriction 
site to allow cloning of the VH and kappa domains into the pSelect DB3 plasmid. 
These sites are as follows: VH domain: 5' primer contains a Xho I site; 3' primer 
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contains a Sac I site, K chain: 5' primer contains a Sac 1 site; 3'primer contains a Hind 
I I I site. These sites further allow the two domains to be cloned together, as follows:-
Figure 3.25 : Diagrammatic representation of the cloning together of VH and kappa 
chains using various restriction sites. 
VH linker K 
Xhol Sad Sad HindHI 
VH 
tVf 
Xhol Sad Hindin 
Using the primers just described, PCR amplification of the VH and kappa 
chains was attempted on RNA extracted from CPY-injected mice, B3B7-injected 
mice, and unimmunised mice. 
As described in section 3.3, numerous parameters were adjusted to try and 
optimise conditions for amplification. For example, MgCh was used at different 
concentrations (of which none worked any better than the original 1.5mM), different 
RNA extraction kits were employed (of which the Stratagene kit appeared to give the 
best results, for the kappa chains at least), and different annealing temperatures were 
tried. (All of the kappa chains amplified better at +3°C, i.e. at 55°C, rather than the 
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recommended 52°C annealing temperature, but it was difficult to assess the effect of 
annealing temperature on the heavy chains because PCR products of the correct size 
were rarely seen for any of the heavy chains). Problems were also encountered 
initially with the primers used. 60 picomoles of each primer was needed for each 
reaction, but when the appropriate primer dilution was analysed by agarose gel 
electrophoresis, it appeared that there was insufficient primer present, and hence no 
PCR products. Consequently, the 'stock' primers were used instead, and although it 
produced improved results, it meant that the absolute amount of primer added was 
inaccurate. However, the most significant improvement in results was observed 
when the spleen was pierced, rather than minced, to remove all the cells prior to 
extraction. Presumably, this was because the RNA was in better condition following 
the more gentle technique. 
Interestingly, it appears that these problems with amplification of 
immunoglobulin genes are not unique. Stinson et. al (1995), who were also 
attempting to generate scFv fragments from spleen cells, found that certain primer 
combinations resulted in no PCR products, or that some amplifications generated 
products that were quite varied in size. (This is particularly interesting because this 
was a feature noted several times in this study, especially for the heavy chain 
amplifications, where products were present but not at the correct size). 
Unfortunately, Stinson et. al. are also unclear about the factors that are involved in 
these odd situations. They do suggest, however, that like many PCR reactions, 
optimisation of the various parameters is what is needed, so maybe with the heavy 
chains in this study, it is simply the case that we hadn't identified the optimum 
conditions for successful amplification. 
Irving et. al (1996) noted in their review that poorer amplification results 
were sometimes obtained when restriction sites (for subsequent cloning) were 
incorporated into the primers. They suggest that this is possibly due to an adverse 
effect of the extra sequence encoding the restriction site being non-complementary to 
the immunoglobulin cDNA. However, although the removal of the restriction sites 
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from the primers used in this study might increase the success of the PCR 
amplifications, the fact that the resulting products could not be cloned into vectors, 
nor subcloned into phage for display, renders this suggestion not an option for 
improvement. Another suggestion proposed by Irving et. al. is to 'hot start' the 
PCR, since this reduces the chance of VH primer-dimers forming, a problem which 
decreases the efficiency of product amplification. 'Hot-starting' involves heating the 
reaction mixture (e.g. to 94°C) before adding the taq polymerase enzyme, and is 
therefore a simple modification which could easily be trialed for this study. 
Unfortunately, the VH domains were not successfijlly amplified here, and 
hence work with the kappa chains was also halted. However, had all amplifications 
been achieved, the technique would have continued as follows. 
All the PCR products from the kappa chain amplifications would have been 
pooled together into one 'kappa pool', and all the PCR products from the VH 
amplifications would have been pooled together into a separate ' V H pool'. Using the 
restriction sites described previously, each PCR product pool would have been 
cloned into the appropriately -cut plasmid pSelect DB3. Thus two libraries of 
fragments in pSelect would been generated - one library for all the different kappa 
chains, and another library for all the different VH domains. The plasmid pSelect 
DB3 contains an ampicillin - resistance gene (directly after the inserted VH or kappa 
gene) that is only expressed if a functional VH or kappa gene has been inserted. 
Thus, by culturing in ampicillin - containing media, it is possible to select for only 
those plasmids which are expressing a fijnctional gene. 
Random recombination of the two genes is then performed by subcloning the 
two libraries together. In other words, using the same restriction sites as described 
earlier, the kappa genes from the kappa chain library are excised and subcloned into 
the VH library (pSelect + VM), and the VH genes from the VH library are excised and 
subcloned into the kappa library (pSelect + kappa), both methods generating 
plasmids containing both VH and kappa genes (pSelect + VH + kappa). Again, the 
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ampicillin resistance gene is only expressed if both genes are present and fiinctional, 
and therefore only successful recombinations are selected. Most pairings in this 
combinatorial repertoire will be artificial (Winter et. aL, 1994), although if the 
libraries were large enough initially, then original pairings are likely to be present. 
At this stage, the recombined gene pairs are excised using Xhol and Hindlll 
and subcloned into a modified strain of the filamentous M13 phage; JCM1388. This 
JCM1388 strain has been modified to contain two copies of the gene VIII (major 
coat) protein, the two having identical amino acid sequences, but different nucleotide 
sequences. One copy of the gene is used to create a fusion product with the VH/K 
construct, such that it may become displayed on the phage surface, while the other, 
wild type gene VII I , is necessary to be displayed normally for the phage to be viable. 
(Winter et. al., 1994). The advantages of using gene VIII over gene I I I are that 
several scFv fragments are incorporated over the phage surface, i.e. it is multivalent, 
allowing a wider range of affinities to be captured, and secondly, that the phage is 
still infective (Kang, Barbas et. al., 1991). 
Each phage contains only one VH and one kappa chain, and therefore displays 
only one species of antibody, just like a B-cell. Furthermore, as with unstimulated 
natural antibodies, most of these scFv fragments are likely to be of low affinity. 
However, just as in the natural immune system, they may undergo 'affinity 
maturation' through various rounds of selection against antigen, and mutation. Once 
a particular scFv fragment (and it's gene) has been selected by phage display, it is 
generally straightforward to transfer the gene to a plasmid system to facilitate both 
mutation and high level expression (Irving et. al., 1996). Since gene technology 
combined with phage display immortalises the genes encoding the desired antibody 
specificities, the potential possibilities for their use, both in scientific research and 
medical treatments is vast. 
Clearly, phage display is an extremely powerful technique, capable of 
overcoming many of the problems faced by hybridoma technology in generating 
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monoclonal antibodies against a wide variety of different antigens. It is a shame that 
only the first step was reached in this study, but it is certain that research into this 
area will continue, and hopefully the technique will be mastered, such that work can 
go on into generating monoclonal antibodies against natural killer cell surface 
markers. From this, the ultimate goal of identifying what surface markers are 
present, and involved in natural killing, is possible. 
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Chapter 4 
Concluding Remarks and Suggestions for 
Further Work 
This study investigated the presence of natural killer cells in the amphibian 
Xenopvs laevis, to determine whether this proposed 'primitive' immune system exists 
at lower levels of evolution (and potentially provide an insight into the development 
of this system). 
Initial studies (detailed in Chapter 2) probed the ability of Xenopus laevis 
lymphocytes to spontaneously lyse allogeneic B3B7 thymic tumour cell targets (which 
is indicative of natural killer cell activity), through the use of ''chromium release 
microcytotoxicity assays. Fresh, untreated splenocytes from control animals 
exhibited only minimal cytotoxic activity, whereas those from early-thymectomised 
animals displayed significant cytotoxicity. This suggested that 'NK - like' activity is 
greater in thymectomised animals (that have no T cells), which is in agreement with 
Janeway (1989) who proposes that NX cells are a primitive form of immune defence, 
active before T cells are fully developed. 
Furthermore, the cytolytic activity observed in splenocytes from a 
thymectomised animal could be significantly enhanced by Con A-derived 
supernatants. (These ASNs, which were generated under optimal conditions were 
likely to be rich in IL-2 or IL-2-like factors (Haynes & Cohen, 1993), and thus would 
be expected to activate natural killer cells). Such enhancement was typical of the 
'lymphokine activated killing' observed by other researchers (Mason et al, 1990; 
Trinchieri et a/., 1984), supporting the theory that tumour cell lysis recorded here 
was mediated by NK-like cells, and hence substantiating the presence of such cells in 
Xenopus laevis. 
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Following this observation, attempts were made to locate the specific cell 
population responsible for the cytolytic activity, by enriching the splenocytes for 
natural killer cells through the selective depletion of other lymphocyte subsets, in 
particular T cells, B cells and Tc cells. Two techniques were employed in this study -
separation by 'panning', and magnetic bead separation, both of which are detailed in 
Chapter 2. On comparison of the two techniques, it was found that both were able to 
deplete a splenocyte culture of B cells to the same extent, but that magnetic sorting 
produced far superior results for depletion of T cells. Further, separation trials could 
have been carried out to try and achieve absolute purity of populations, but at this 
point it was deemed unnecessary since sufficient purity had been achieved to allow 
further cytolytic and molecular work to be undertaken. Thus, under conditions 
determined in this study as optimum for magnetic sorting, various 'purified' 
populations were generated, which were then assessed for their cytotoxic activity in 
^'chromium release microcytotoxicity assays. These preliminary analyses suggested 
that natural killer - like activity in Xenopus is likely to be mediated by a 'non-T / non-
B' lymphoid subset. However, more detailed analysis is required to confirm this. In 
particular, a mAb against NK cell surface antigens would be an extremely useful tool 
for enriching NK populations through magnetic sorting. 
Work detailed in Chapter 3 outlines preliminary investigations designed to 
address the problem of generating such mAbs against NK cell surface antigens. 
These initial experiments attempted to develop the technique of 'phage display' for 
the generation of single chain Fv antibody fragments against chosen antigens. In 
order to learn the technique, trials were made against the single antigen 
Carboxypeptidase Y, and a population of B3B7 Xetiopus thymic tumour cells, 
although ultimately mAbs would have been generated against enriched natural killer 
cell populations. Following RNA extraction under conditions determined as 
optimum. Kappa light chains were successftjlly amplified from the experimental 
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spleens, but unfortunately the VH chains were not, which meant that work could not 
continue. 
However, in the period since the research for this thesis was completed, work 
has continued in the laboratory, and now both Kappa and VH chains have been 
successfully amplified (Martin Watson - personal communication). VH chains were 
finally amplified using Reverse Transcriptase PCR (RT - PCR), which incorporates 
the transcription of RNA into cDNA with the PCR amplification into one reaction 
mix. Furthermore, trials have been made using rat spleen RNA rather than mouse 
spleen RNA, and have produced surprisingly good results - in fact, better bands were 
achieved than with the murine system for both Kappa and VH chains!! Consequently, 
it seems likely that rats will be used for future immunization and antibody-generation 
purposes. 
Given that both VH and Kappa have now been successfully amplified, the rest 
of the technology could now be continued as detailed in Chapter 3 (section 3.4). 
Providing that this progressed well, and an antibody-displaying phage population was 
successfully generated, a further goal of any future work would be to select all phage 
that are displaying antibodies against NK cell surface antigens. According to de 
Kruif et al. (1996), there are four steps in the selection of phage-Abs from libraries: 
"(1) binding of phages to the target antigen; (2) removal of nonbound phages by 
washing; (3) elution of bound phages; and (4) infection and propagation of eluted 
phages in Escherichia coli." Various techniques have been employed for such 
selection, including binding of the phage-Abs to purified antigens coated on to plastic 
surfaces, capture on to a solid phase through monoclonal antibodies, selection using 
intact eukaryotic cells (in suspension or as monolayers) as targets, or even using flow 
cytometric sorting with fluorochrome-labeled mAbs against the required 
subpopulation of cells (de Kruif et al., 1996). 
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For this study, where phage-Abs are to be generated against whole natural 
killer cells, the technique of choice would be to mix phage-Abs with the enriched NK 
cell population, and then to centrifiige the mix. Phage which are displaying 
antibodies against NK cell surface antigens will bind to the cells and be centrifuged 
down to the bottom of the tube as a pellet. The other phage (displaying non-NK cell 
antibodies) will remain in solution and can be removed in the supernatant. Once 
these selected phage-Abs have been purified, a further, long-term goal of the project 
could be to characterize the antibodies and identify the surface antigens that they bind 
to (involving such techniques as Western blotting and SDS-PAGE [sodium dodecyl 
sulphate polyacrylamide gel electrophoresis]). 
Although beyond the scope of this study, these suggestions are exciting and 
realistic possibilities for long-term investigation. The work detailed here provides a 
sound and thorough basis from which such possibilities can be developed, and will 
provide useful information regarding the evolution of natural killer cells within the 
immune system. 
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Appendix A 
Murine Immunoglobulin P C R Primers 
The primers used in this study for the amplification of murine immunoglobulin genes 
were those detailed by Kang, Burton and Lerner (1991), and were named 
Lcl,3,4,5,6,7, and Hcl,2,3,4,5,6,7,8,9 as follows : 
Murine light-chain variable 5' primers 
Lcl : 5'-CCA GTT CCG AGC TCG TTG TGA CTC AGG AAT CT-3' 
Lc3 : 5'-CCA GTT CCG AGC TCG TGC TCA CCC AGT CTC CA-3' 
Lc4 : 5' -CCA GTT CCG AGC TCC AG A TGA CCC AGT CTC CA-3' 
Lc5 : 5 '-CCA GAT GTG AGC TCG TGA TGA CCC AGA CTC CA-3' 
Lc6 : 5'-CCA GAT GTG AGC TCG TCA TGA CCC AGT CTC CA-3' 
Lc7 : 5'-CCA GTT CCG AGC TCG TGA TGA CAC AGT CTC CA-3' 
Heavy-chain variable 5' primers 
Hcl : 5'- AGG TCC AGC TGC TCG AGT CTG G-3' 
Hc2 : 5'-AGG TCC AGC TGC TCG AGT CAG G-3' 
Hc3 : 5' - AGG TCC AGC TTC TCG AGT CTG G-3' 
Hc4 : 5'-AGG TCC AGC TTC TCG AGT CAG G-3' 
Hc5 : 5'-AGG TCC AAC TGC TCG AGT CTG G-3' 
Hc6 : 5'-AGG TCC AAC TGC TCG AGT CAG G-3' 
Hc7: 5'-AGG TCC AAC TTC TCG AGT CTG G-3' 
Hc8 : 5'- AGG TCC AAC TTC TCG AGT CAG G-3' 
Hc9 : 5'-AGG TII AIC TIC TCG AGT C(TA)G G-3' 
I = Inosine 
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DB3-BLAB (Murine kappa chain 3' primer) 
5'-TCT AGA AGC TTG CCC ACC CTC ATT CCT GTT GAA GCT-3' 
MVH-LINK (Murine heavy chain 3' primer) 
5'-CTG GGT CAT CTG GAG CTC GGC CAG TGG ATA GAC AGA TGG GGG 
TGT CGT TTTGGC-3' 
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